@kerstin wg. supplementa

[nina:)]

liebe kerstin,
wahrscheinlich hast du‘s überlesen, deshalb kopier ich meine antwort auf deinen supplementa-rat nochmal hierher. wär super wenn du noch antworten könntest:
<i>
....
bei supplementa war ich schon. das problem ist da, dass mir nicht ganz klar ist, wieviel reines zink da nun wirklich drin ist. sind es wirklich 50 mg? (dann wärs mir zu viel) oder sind es nur 50mg zink-verbindungen? (dann wärs wahrscheinlich viel weniger). zum vergleich: das zink-präparat, dass ich kaufen wollte, enthält 140mg zink-gluconat, das entspricht 20 mg reines zink. .....
<i>
liebe grüße,
nina:)

[Kerstin]

Liebe nina:),
nee, ich habs nicht überlesen, aber ich habe keine Antwort darauf.
Frag mal Mic, der weiß es vielleicht.
Liebe Grüßé
Kerstin

[Mic]

>Liebe nina:),
>
>nee, ich habs nicht überlesen, aber ich habe keine Antwort darauf.
>Frag mal Mic, der weiß es vielleicht.
>
>Liebe Grüßé
>Kerstin
Hallo ihr Zwei,
schweisesauchnüsch! Aber nach der Beschreibung von Supplementa (Eine Tablette enthält: Zink (aus Citrat, Aminosäure-Chelat, Picolinat) 50 mg) würde ich mal schwer annehmen es handelt sich tatsächlich um 50 mg Zink, nicht 50 mg Zinkverbindungen. Vielleicht steht es auf der Dose genauer drauf, bestellt hat es wohl noch keiner, oder?
Also wirklich zuviel Zink hättest du mit 50 mg sicher auch nicht nina, dein KPU Wert liegt mit 31 ja nicht gerade am unteren Rand, das ist schon stark erhöht. Bei Kryptosan würde man dir wohl so 3-4 Kapseln am Tag empfehlen als Enddosis für die ersten Monate. Also etwa 20-30 mg Zink. Ob Zink als Citrat ebenso gut aufgenommen wird wie als Gluconat entzieht sich bislang meiner Kenntnis, ich vermute eher mal nicht. Aber sicher immer noch besser als die Zinksulfat-Brausetabletten. Ausserdem kann man die Tri-Zink sicher auch grob halbieren. Letztlich ist eh entscheidend wieviel Zink in deinem Körper in den Zellen ankommt und nicht wieviel du einwirfst (das entscheidet höchstens der Geldbeutel).
Liebe Grüße,
Mic

[Kerstin]

Hi Mic,
doch, ich habs bestellt und nehm es auch schon seit langem in unregelmäßigen Abständen.
Guck doch bei Supplementa mal nach auf der Site, unter Warengruppe -> Mineralstoffe einzeln.
Das steht auch nur:
Eine Tablette enthält:
Zink (aus Citrat, Aminosäure-Chelat, Picolinat) 50 mg
Gebrauchsempfehlung:
Als Nahrungsergänzung 1 Tablette täglich, mit einer Mahlzeit.
Sonstige Inhaltsstoffe:
Reisstärke, Magnesiumstearat, Gelatine (Kapsel).
Frei von:
Hefe, Weizen, Mais, Milch, Ei, Soja, Gluten, Zucker, Stärke, tierischen Bestandteilen, künstlichen Farb-, Aroma-, Geschmacks- und Konservierungsstoffen.
Hersteller:
KAL(r) Inc., Park City, Utah/USA
Übrigens gibts da auch ein Gemisch aus Zink und Mangan:
Eine Tablette enthält:
Zink (Chelat) 100 mg
Mangan (Gluconat) 5 mg
Gebrauchsempfehlung:
Als Nahrungsergänzung 1 Tablette täglich, am besten abends, mit einer Mahlzeit. Nicht überdosieren.
Sonstige Inhaltsstoffe:
Pflanzliches Stearin, Magnesiumstearat, Akacia, Zellulose.
Frei von:
Hefe, Weizen, Mais, Milch, Ei, Soja, Gluten, tierischen Bestandteilen, Zucker, Stärke, künstlichen Farb- und Konservierungsstoffen.
Geeignet für Vegetarier.
Hersteller:
KAL(r) Inc., Park City, Utah/USA
Aber 100 Zink is vielleicht a bissel viel, oder?
LG
Kerstin

[anne]

nur mal noch ein tip nebenbei, der auch schon paar mal durch forum gegeistert ist.
áls alternative zu supplementa kann man mineralien und vitamine und all so n zeugs auch unter www.vitaviva.com bestellen. dort gibts ganz viele super sonderangebote - wirklich unglaublich billig, auch wenn dafür der versand und das einpacken mehr kostet. zinkpräperate habe die natürlcih auch, mit ganz guten angaben. guckt doch einfach mal nach
sonnige grüße,
anne

[Mic]

Hallo zusammen,
dies ist ein Auszug aus dem deutschen Text zur Gärtner-Studie, den mir Nicole (Blue) dankenswerterweise geschickt hat. Er unterstreicht nochmal deutlich was ich bereits mehrfach in meinen Beiträgen angesprochen habe. Das Problem der Jodsubstitution bei Hashi hängt in erster Linie mit einem gleichzeitig bestehenden Selenmangel zusammen (extreme Jodüberempfindlichkeitsreaktionen wie die von Simona mal ausgenommen). Jod an sich ist gar nicht sooo <em>das</em> Problem, gefährlich ist die alleinige Jodsubstitution bei weiter bestehendem Selenmangel (bei MB kann Jod natürlich auch zu einer ÜF beitragen). Hier liegt der Hase im Pfeffer, und das dürfte auch die Ursache für die Zunahme der SD-Autoimmunerkrankungen seit Beginn der Jodierungskampagnen in vielen Ländern sein. Von natur aus jodreiche Nahrungsmittel wie Seefisch/Meeresfrüchte enthalten gleichzeitig auch immer ausreichend Selen (wenngleich das durch die Belastung mit Quecksilber und anderen Schwermetallen leider immer weniger davon bioverfügbar ist). Die Substitution mit Jodsalz aber hat zu einem massiven Ungleichgewicht zwischen Jod und Selenaufnahme geführt und daher (vermutlich kausal) zu einer Zunahme von Immunthyreopathien (Hashimoto, Morbus Basedow) geführt. Bei der Verarbeitung des Jods in der SD zu SD-Hormonen entstehen große Mengen Sauerstoffradikale die normalerweise von der Glutathion-Peroxidase (GPx), einem selenhaltigen Enzym abgefangen werden, damit sie keinen Schaden anrichten können. Bei Selenmangel (verminderte GPx-Aktivität) und Defiziten an weiteren Antioxidantien schädigt jedes in die SD aufgenommene und verarbeitete Jod diese und kann dadurch einen Autoimmunprozess in Gang setzen bzw. weiter fördern.
Die künstliche Jodierung ist daher viel problematischer als von natur aus jodreiche Nahrungsmittel. Zum Ausgleich sollte man sie auf alle Fälle durch eine ausreichende Selenversorgung kompensieren, da man ihr ja leider nicht 100 %ig entkommt. Das gilt auch vorbeugend, v.a. bei Kindern von betroffenen Eltern. Jodvermeidung ist gut, Selenversorgung ist besser. Jodvermeidung ist auch nur sinnvoll, wo durch ohnehin notwendige Hormoneinnahme eine ausreichende Versorgung möglich ist. Muss jemand keine Hormone nehmen (z.B. Kinder von Betroffenen), sollte man auf eine ausreichende Selenversorgung <em>UND</em> Jodversorgung achten (sonst ist die Hormonversorgung wieder nicht optimal), letzteres aber bevorzugt über natürliche Lebensmittel mit höherem Jodgehalt. Leider sind diese oft schwermetallbelastet, was erst recht zusätzliches Selen erfordert. Ebenso bei vorhandenen Amalgamfüllungen. Das ganze ist wiedermal ein Beispiel wie der Mensch oft vorschnell, mit unvollständigem Wissen, in die natürlichen Abläufe eingreift. Leider ja alles andere als ein Einzelfall ...
LG, Mic
<font face="Times New Roman, Roman, Times" size="12">
<big><b>Selen und Immunthyreopathie</b></big>
Roland Gärtner, Medizinische Klinik Universität München, Campus Innenstadt<br>
In Gegenden mit ausgeprägtem Selen- und Jodmangel (Zaire, China) findet man schon bei Kleinkindern eine hohe Inzidenz einer atrophischen Thyreoiditis und myxödematösem Kretinismus. Eine alleinige Jodidsubstitution verstärkt die Destruktion der Schilddrüse, eine ausreichende Selensubstitution vor der Jodidsubstitution kann diese verhindern. Auch in Gegenden mit einem milden Selenmangel besteht eine inverse Korrelation zwischen Plasma - Selenspiegeln und der Inzidenz einer Autoimmunthyreoiditis (AIT), wie in der großen epidemiologischen Studie aus Frankreich bei über 2000 Testpersonen (SU.VI.MAX) gezeigt. <br>Aus tierexperimentellen Untersuchungen ist schon lange bekannt, dass ein Selenmangel in der Nahrung mit einer verminderte GPx - Aktivität in den Schilddrüsenzellen einhergeht. Dadurch werden weniger Sauerstoffradikale, die während der Schilddrüsenhormonsynthese gebildet werden reduziert und die Schilddrüsenzellen dadurch geschädigt. Eine ausreichende Selenzufuhr normalisiert die GPx - Aktivität in den Zellen und verhindert eine Zellschädigung.
Selen-abhängige Enzyme haben außerdem eine Schlüsselstellung in der Immunreaktion. So kommt es bei Selenmangel zu einer eher überschießenden Immunreaktion mit Gewebedestruktion, z.B. bei Viruspneumonien häufiger zum ARDS, bei Sepsis häufiger zum Multiorganversagen. Bei Autoimmunerkrankungen wie M.Crohn oder rheumatoider Arthritis ist der Selenspiegel und damit die GPx-Aktivität im Serum invers zur Krankheitsaktivität korreliert. </font>

[Mic]

Hallo zusammen,
dies ist ein Auszug aus dem deutschen Text zur Gärtner-Studie, den mir Nicole (Blue) dankenswerterweise geschickt hat. Er unterstreicht nochmal deutlich was ich bereits mehrfach in meinen Beiträgen angesprochen habe. Das Problem der Jodsubstitution bei Hashi hängt in erster Linie mit einem gleichzeitig bestehenden Selenmangel zusammen (extreme Jodüberempfindlichkeitsreaktionen wie die von Simona mal ausgenommen). Jod an sich ist gar nicht sooo <em>das</em> Problem, gefährlich ist die alleinige Jodsubstitution bei weiter bestehendem Selenmangel (bei MB kann Jod natürlich auch zu einer ÜF beitragen). Hier liegt der Hase im Pfeffer, und das dürfte auch die Ursache für die Zunahme der SD-Autoimmunerkrankungen seit Beginn der Jodierungskampagnen in vielen Ländern sein. Von natur aus jodreiche Nahrungsmittel wie Seefisch/Meeresfrüchte enthalten gleichzeitig auch immer ausreichend Selen (wenngleich das durch die Belastung mit Quecksilber und anderen Schwermetallen leider immer weniger davon bioverfügbar ist). Die Substitution mit Jodsalz aber hat zu einem massiven Ungleichgewicht zwischen Jod und Selenaufnahme geführt und daher (vermutlich kausal) zu einer Zunahme von Immunthyreopathien (Hashimoto, Morbus Basedow) geführt. Bei der Verarbeitung des Jods in der SD zu SD-Hormonen entstehen große Mengen Sauerstoffradikale die normalerweise von der Glutathion-Peroxidase (GPx), einem selenhaltigen Enzym abgefangen werden, damit sie keinen Schaden anrichten können. Bei Selenmangel (verminderte GPx-Aktivität) und Defiziten an weiteren Antioxidantien schädigt jedes in die SD aufgenommene und verarbeitete Jod diese und kann dadurch einen Autoimmunprozess in Gang setzen bzw. weiter fördern.
Die künstliche Jodierung ist daher viel problematischer als von natur aus jodreiche Nahrungsmittel. Zum Ausgleich sollte man sie auf alle Fälle durch eine ausreichende Selenversorgung kompensieren, da man ihr ja leider nicht 100 %ig entkommt. Das gilt auch vorbeugend, v.a. bei Kindern von betroffenen Eltern. Jodvermeidung ist gut, Selenversorgung ist besser. Jodvermeidung ist auch nur sinnvoll, wo durch ohnehin notwendige Hormoneinnahme eine ausreichende Versorgung möglich ist. Muss jemand keine Hormone nehmen (z.B. Kinder von Betroffenen), sollte man auf eine ausreichende Selenversorgung <em>UND</em> Jodversorgung achten (sonst ist die Hormonversorgung wieder nicht optimal), letzteres aber bevorzugt über natürliche Lebensmittel mit höherem Jodgehalt. Leider sind diese oft schwermetallbelastet, was erst recht zusätzliches Selen erfordert. Ebenso bei vorhandenen Amalgamfüllungen. Das ganze ist wiedermal ein Beispiel wie der Mensch oft vorschnell, mit unvollständigem Wissen, in die natürlichen Abläufe eingreift. Leider ja alles andere als ein Einzelfall ...
LG, Mic
<font face="Times New Roman, Roman, Times" size="+1">
<big><b>Selen und Immunthyreopathie</b></big>
Roland Gärtner, Medizinische Klinik Universität München, Campus Innenstadt<br>
In Gegenden mit ausgeprägtem Selen- und Jodmangel (Zaire, China) findet man schon bei Kleinkindern eine hohe Inzidenz einer atrophischen Thyreoiditis und myxödematösem Kretinismus. Eine alleinige Jodidsubstitution verstärkt die Destruktion der Schilddrüse, eine ausreichende Selensubstitution vor der Jodidsubstitution kann diese verhindern. Auch in Gegenden mit einem milden Selenmangel besteht eine inverse Korrelation zwischen Plasma - Selenspiegeln und der Inzidenz einer Autoimmunthyreoiditis (AIT), wie in der großen epidemiologischen Studie aus Frankreich bei über 2000 Testpersonen (SU.VI.MAX) gezeigt. <br>Aus tierexperimentellen Untersuchungen ist schon lange bekannt, dass ein Selenmangel in der Nahrung mit einer verminderte GPx - Aktivität in den Schilddrüsenzellen einhergeht. Dadurch werden weniger Sauerstoffradikale, die während der Schilddrüsenhormonsynthese gebildet werden reduziert und die Schilddrüsenzellen dadurch geschädigt. Eine ausreichende Selenzufuhr normalisiert die GPx - Aktivität in den Zellen und verhindert eine Zellschädigung.
Selen-abhängige Enzyme haben außerdem eine Schlüsselstellung in der Immunreaktion. So kommt es bei Selenmangel zu einer eher überschießenden Immunreaktion mit Gewebedestruktion, z.B. bei Viruspneumonien häufiger zum ARDS, bei Sepsis häufiger zum Multiorganversagen. Bei Autoimmunerkrankungen wie M.Crohn oder rheumatoider Arthritis ist der Selenspiegel und damit die GPx-Aktivität im Serum invers zur Krankheitsaktivität korreliert. </font>

[Mic]

Allgemeine Infos zu Symptomatik und Diagnose:
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1106144375">KPU-Beschreibung, Symptome, Links</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=48670564">Testmöglichkeiten/Laborkosten</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=422574476">Hinweise zur Testdurchführung</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=214927862">Zink- und B6-Mangel richtig im Labor bestimmen</A>
Therapie:
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=461901529">Was ist Kryptosan?</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=648771734">Zusammensetzung Kryptosan von Präventa-Pharm</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=960588362">Zusammensetzung Kryptosan und Pyridoxin Plus von Tech-Med</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=192160077">Empfehlungen und Tipps zu Einzelsubstanzen statt KS</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=989496030">Therapie-Empfehlungen und Medikament-Holland</a>
Spezielles:
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1089240907">10 Fragen zu KPU - 10 Antworten</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=345371145">Lebenslauf eines HPU´lers</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=621413493">Zähne und andere Zusammenhänge</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=223727112">KPU-Hashi-Traumerinnerung</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=365481976">Eisen + Selen und andere Medikamente auch absetzen vor KPU-Test?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=537423394">Diverses, u.a. Mangelursachen, Medikamente absetzen/Testvoraussetzungen</A>
<TITLE>Pyrrolurie-Linksammlung</TITLE>
<H2>Sonstige Links:</H2>
<DL><p>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=377090090&NOTHREAD=&PAGE=1" ADD_DATE="1037878728" LAST_VISIT="1047510000" LAST_MODIFIED="1037878730">HPU=Porphyrie - Ja!</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=325339854&NOTHREAD=&PAGE=1" ADD_DATE="1037884238" LAST_VISIT="1047510000" LAST_MODIFIED="1037884240">Hoher Ruhepuls bei Porphyrien - Neuropathie des Vegetativums</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=908289411&NOTHREAD=&PAGE=2" ADD_DATE="1038672670" LAST_VISIT="1047510000" LAST_MODIFIED="1038672672">Porphyrie-Symptome und Links/Zusammenhang mit KPU/HPU</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=375056038&NOTHREAD=&PAGE=2" ADD_DATE="1038818774" LAST_VISIT="1047510000" LAST_MODIFIED="1038818776">Porphyrie-Board am MGH Harvard</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=460672164&NOTHREAD=&PAGE=1" ADD_DATE="1038923325" LAST_VISIT="1047510000" LAST_MODIFIED="1039606428">Vergleich Autofabrik Enzyme - Roboter</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=625395217&NOTHREAD=&PAGE=1" ADD_DATE="1040642547" LAST_VISIT="1047510000" LAST_MODIFIED="1040642548">Hypophysen-UF und Serotonin-Mangel - Nährstoffmangel, ADS + KPU</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=145960787&NOTHREAD=&PAGE=1" ADD_DATE="1042898784" LAST_VISIT="1047510000" LAST_MODIFIED="1042898786">Tryptophan - Wirkung, Serotonin - B6-Mangel</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1070162623&NOTHREAD=&PAGE=1" ADD_DATE="1042905187" LAST_VISIT="1047510000" LAST_MODIFIED="1042905188">Bei B6-Mangel auch Unverträglichkeit von SD-Hormon möglich</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=787356317" ADD_DATE="1046874187" LAST_VISIT="1046818800" LAST_MODIFIED="1046874188">Selen und Referenzbereich + Wie wirken eigentlich SD-Hormone? Was hat das mit KPU zu tun?</A>
<DT><A HREF="http://www.morbusbasedow.de/cgi-bin/mb-forum.exe?VIEWID=934088853" ADD_DATE="1045062859" LAST_VISIT="1047510000" LAST_MODIFIED="1045062860">Kryptosan Nebenwirkungen - Ursachen und Zusammenhänge</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1044155782&NOTHREAD=&PAGE=1" ADD_DATE="1045354063" LAST_VISIT="1047510000" LAST_MODIFIED="1045354064">Serotonin und gestörte Hämsynthese</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=411521280&NOTHREAD=&PAGE=1" ADD_DATE="1045523928" LAST_VISIT="1047510000" LAST_MODIFIED="1045523930">Kohlehydrate bei Porphyrie</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=302757673&NOTHREAD=&PAGE=1" ADD_DATE="1045528716" LAST_VISIT="1047510000" LAST_MODIFIED="1045528718">KPU-Philosophie</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=71759653&NOTHREAD=&PAGE=1" ADD_DATE="1045205736" LAST_VISIT="1047510000" LAST_MODIFIED="1045205738">Störung im Serotonin-Haushalt</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=929786242" ADD_DATE="1046263469" LAST_VISIT="1047510000" LAST_MODIFIED="1046263470">Bei Eisenmangelanämie die auf B-Vitamine anspricht ...</A>
<DT><A HREF="http://f11.parsimony.net/forum16512/messages/35014.htm" ADD_DATE="1046737247" LAST_VISIT="1047510000" LAST_MODIFIED="1046737248">Wissenschaftliche Grundlagen zu KPU/Literatur - Amalgam als Ursache?</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=127517034" ADD_DATE="1047467654" LAST_VISIT="1047423600" LAST_MODIFIED="1047467656">HPU verschlimmert sich durch SD-Hormone?</A>
</DL><p>

[Mic]

<TITLE>Pyrrolurie-Linksammlung</TITLE>
<H3>Allgemeine Infos zu Symptomatik und Diagnose:</H3><a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1106144375">KPU-Beschreibung, Symptom-Checkliste, Links</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=48670564">Testmöglichkeiten/Laborkosten</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=422574476">Hinweise zur Testdurchführung</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=214927862">Zink- und B6-Mangel richtig im Labor bestimmen</A>
<H3>Therapie:</H3><a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=461901529">Was ist Kryptosan?</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=648771734">Zusammensetzung Kryptosan von Präventa-Pharm</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=960588362">Zusammensetzung Kryptosan und Pyridoxin Plus von Tech-Med</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=459898902">Empfehlungen und Tipps zu Einzelsubstanzen statt KS</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=989496030">Therapie-Empfehlungen und Medikament-Holland</a>
<A HREF="http://www.morbusbasedow.de/cgi-bin/mb-forum.exe?VIEWID=934088853">Kryptosan Nebenwirkungen - Ursachen und Zusammenhänge</A>
<H3>Spezielles:</H3><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1089240907">10 Fragen zu KPU - 10 Antworten</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=345371145">Lebenslauf eines HPU´lers</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=621413493">Zähne und andere Zusammenhänge</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=223727112">KPU-Hashi-Traumerinnerung</a>
<b>KPU und ADS/Serotoninmangel</b>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=131476133">ADS und KPU - ein Betroffener ;-)</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=625395217">Hypophysen-UF und Serotonin-Mangel - Nährstoffmangel, ADS + KPU</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=145960787">Tryptophan-Wirkung, Serotonin - B6-Mangel</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1044155782">Serotonin und gestörte Hämsynthese</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=71759653">Störung im Serotonin-Haushalt</A>
<b>KPU-Test und Medikamente:</b>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=365481976">Eisen + Selen und andere Medikamente auch absetzen vor KPU-Test?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=537423394">Diverses, u.a. Mangelursachen, Medikamente absetzen/Testvoraussetzungen</A>
<b>KPU und Porphyrien:</b>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=377090090">HPU = Porphyrie?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=325339854">Hoher Ruhepuls bei Porphyrien - Neuropathie des Vegetativums</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=411521280">Kohlehydrate und Sugar-Craving bei Porphyrie?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=523944246">weiterführende Links Porphyrie und Pyrrolurie</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=375056038">Porphyrie-Board am MGH Harvard</A>
<b>KPU und Schilddrüsenhormone:</b>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=787356317">Selen und Referenzbereich + Wie wirken eigentlich SD-Hormone? Was hat das mit KPU zu tun?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=127517034">HPU verschlimmert sich durch SD-Hormone?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1070162623">Bei B6-Mangel auch Unverträglichkeit von SD-Hormon möglich</A>
<H3>Sonstiges:</H3>
<DL><p>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=428575522">Enzyme der Hämsynthese: Vergleich Autofabrik - Roboter</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=302757673">KPU - Philosophisches</A>
<DT><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=929786242">Bei "Eisenmangelanämie" die auf B-Vitamine anspricht ...</A>
<DT><A HREF="http://f11.parsimony.net/forum16512/messages/35014.htm" target="_blank">Ist KPU nur eine Erfindung von Geschäftemachern? Ist Amalgam die wahre Ursache? <br>Wissenschaftliches Fundament zu KPU/Literaturstellen in "Nature" und "Lancet"</A>
</DL><p>

[Mic]

<TITLE>Pyrrolurie-Linksammlung</TITLE>
<H3>Allgemeine Infos zu Symptomatik und Diagnose:</H3><a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1106144375">KPU-Beschreibung, Symptom-Checkliste, Links</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=48670564">Testmöglichkeiten/Laborkosten</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=422574476">Hinweise zur Testdurchführung</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=214927862">Zink- und B6-Mangel richtig im Labor bestimmen</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=437660650">Vitamine und Mineralstoffe im Labor</a>
<br>
<H3>Therapie:</H3><a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=461901529">Was ist Kryptosan?</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=248227585">Anmerkungen/Erläuterung zu Pyrrolurie und Kryptosan</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=648771734">Zusammensetzung Kryptosan von Präventa-Pharm</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=960588362">Zusammensetzung Kryptosan und Pyridoxin Plus von Tech-Med</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=459898902">Empfehlungen und Tipps zu Einzelsubstanzen statt KS</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=989496030">Kommentierte KEAC-Therapie-Empfehlungen (Holland/Depyrrol)</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=202784212">Depyrrol-Erfahrungen</a>
<A HREF="http://www.morbusbasedow.de/cgi-bin/mb-forum.exe?VIEWID=934088853">Kryptosan Nebenwirkungen - Ursachen und Zusammenhänge</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=37631341">Von Großbaustellen und kleineren Sanierungsarbeiten ;-) - Prinzip orthomolekularer Therapie</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=521183502">Wieviel Vitamin B6? - Kritische Dosis?</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=277904961">Zink- und Selenpräparate</a>
<br>
<H3>Spezielles:</H3><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1089240907">10 Fragen zu KPU - 10 Antworten</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=345371145">Lebenslauf eines HPU´lers</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=621413493">Zähne und andere Zusammenhänge</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=223727112">KPU-Hashi-Traumerinnerung</a>
<b>KPU und ADS/Serotoninmangel</b>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=131476133">ADS und KPU - ein Betroffener ;-)</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=625395217">Hypophysen-UF und Serotonin-Mangel - Nährstoffmangel, ADS + KPU</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=145960787">Tryptophan-Wirkung, Serotonin - B6-Mangel</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=561207862">Serotonin/5HTP + Hämsynthese für Interessierte (mit Literaturlinks zu KPU)</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=725197388">Störung im Serotonin-Haushalt</A>
<b>KPU-Test und Medikamente:</b>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=111783256">HPU Test verfälscht durch SD-Unter-/Überfunktion?</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=428568762">HPU-Test und Menstruation</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=365481976">Eisen + Selen und andere Medikamente auch absetzen vor KPU-Test?</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=803309159">Antibiotika und HPU/KPU-Test</a>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=537423394">Diverses, u.a. Mangelursachen, Medikamente absetzen/Testvoraussetzungen</A>
<b>KPU und Porphyrien:</b>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=377090090">HPU = Porphyrie?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=325339854">Hoher Ruhepuls bei Porphyrien - Neuropathie des Vegetativums</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=411521280">Kohlehydrate und Sugar-Craving bei Porphyrie?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=523944246">weiterführende Links Porphyrie und Pyrrolurie</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=375056038">Porphyrie-Board am MGH Harvard</A>
<b>KPU und Schilddrüsenhormone:</b>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=787356317">Selen und Referenzbereich + Wie wirken eigentlich SD-Hormone? Was hat das mit KPU zu tun?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=127517034">HPU verschlimmert sich durch SD-Hormone?</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=1070162623">Bei B6-Mangel auch Unverträglichkeit von SD-Hormon möglich</A>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=111783256">HPU Test verfälscht durch SD-Unter-/Überfunktion?</a>
<a href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=529148574">Aussagefähigkeit der KPU-Werte bei SD-Erkrankung</a>
<br>
<H3>Sonstiges/Literatur:</H3><A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=428575522">Enzyme der Hämsynthese: Vergleich Autofabrik - Roboter</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=302757673">KPU - Philosophisches</A>
<A HREF="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=929786242">Bei "Eisenmangelanämie" die auf B-Vitamine anspricht ...</A>
<A HREF="http://f11.parsimony.net/forum16512/messages/35014.htm" target="_blank">Ist KPU nur eine Erfindung von Geschäftemachern? Ist Amalgam die wahre Ursache? <br>Wissenschaftliches Fundament zu KPU/Literaturstellen in "Nature" und "Lancet"</A>
<a href="http://www.orthomedis.ch/krypto2.htm" target="_blank">Literatursammlung zu KPU bei orthomedis.ch</a>
<a href="http://www.hputest.nl/literatuur.htm" target="_blank">Literatursammlung zu KPU bei hputest.nl</a>

[Mic]

<A name=references><B>References</B></A><P>
<DIV class=jourcontentblack>
<P></P>
<P></P>1 Macalpine I, Hunter R. The "insanity" of King George III: a classic
case of porphyria. BMJ 1966; 1: 65-71.
<P></P>
<P></P>2 Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In:
Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited
disease. 6th ed. New York: McGraw-Hill, 1989: 1305-65.
<P></P>
<P></P>3 Westfall RC. Isolation of porphobilinogen from the urine of a patient
with acute porphyria. Nature 1952; 170: 614-16.
<P></P>
<P></P>4 Brode WR, Pearson EG, Wyman GM. The relation between the absorption
spectra and chemical constitution of dyes. XXVII Cis-trans isomerization in
indigo dyes. J Am Chem Soc 1954; 76: 1034-36.
<P></P>
<P></P>5 Gehauf B, Goldenson J. Detection and estimation of nerve gases by
fluorescence reaction. Anal Chem 1957; 29: 276-78.
<P></P>
<P></P>6 Guilbaut GB, Kramer DW. Resorufin butyrate and indoxyl acetate as
fluorogenic substrates for cholinesterases. Anal Chem 1965; 37: 120-23.
<P></P>
<P></P>7 Munk W. The life of Sir Henry Halford. London &amp; New York: Longmans,
Green &amp; Co, 1895.
<P></P>
<P></P>8 Halford H. Essays and orations, read and delivered at the Royal College
of Physicians. 2nd ed. London: John Murray, 1833.
<P></P>
<P></P>9 Macalpine I, Hunter R. Porphyria: a royal malady. London: British
Medical Association, 1968.
<P></P>
<P></P>10 Macalpine I, Hunter R. George III and the mad business. London: Allen
Lane, Penguin Press, 1969.
<P></P>
<P></P>11 Dean G. The porphyrias: a story of inheritance and environment. 2nd
ed. London: Pitman Medical, 1971.
<P></P>
<P></P>12 Wood WA, Gunsalus IC, Umbreit WW. Function of pyridoxal phosphate:
resolution and purification of the tryptophanase enzyme of Escherichia coli. J
Biol Chem 1947; 170: 313-21.
<P></P>
<P></P>13 Fordtran JS, Scroggie WB, Polter DE. Colonic absorption of tryptophan
metabolites in man. J Lab Clin Med 1964; 64: <BR>125-32.
<P></P>
<P></P>14 Marko AM, Reynolds FB. A colorimetric method for measuring indican.
Can J Biochem Physiol 1960; 38: 253-62.
<P></P>
<P></P>15 Dealler SF, Hawkey PM, Millar MR. Enzymatic degradation of urinary
indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the
purple urine bag syndrome. J Clin Microbiol 1988; 26: 2125-56.
<P></P>
<P></P>16 Rodnight R, McIlwain H. Indicanuria and psychosis of a pellagrin.
<BR>J Ment Sci 1955; 101: 884-89.
<P></P>
<P></P>17 Jepson JB. Hartnup disease. In: Stanbury JB, Wyngaarden JB,
Fredrickson DS, eds. The metabolic basis of inherited disease. 3rd ed. New York:
McGraw-Hill, 1972: 1486-503.
<P></P>
<P></P>18 Rimington C. Indigoid pigments derived from a pathological urine.
Biochem J 1946; 40: 669-74.
<P></P>
<P></P>19 Drummond KN, Michael AF, Ulstrom RA, Good RA. The blue diaper
syndrome: familial hypercalcemia with nephrocalcinosis and indicanuria. Am J Med
1964; 37: 928-48.
<P></P>
<P></P>20 Ludwig GD, Epstein IS. A genetic study of two families having the
acute intermittent type of porphyria. Ann Intern Med 1961; 55: 81-93.
<P></P>
<P></P>21 Price JM, Brown RR, Peters HA. Tryptophan metabolism in porphyria,
schizophrenia, and a variety of neurologic psychiatric diseases. Neurology 1959;
9: 456-68.
<P></P>
<P></P>22 Sprince H. Indole metabolism in mental illness. Clin Chem 1961; 7:
203-30.

[Mic]

[Mic]

<a name=references><b><span lang=EN-GB style=&lsquo;mso-ansi-language:
EN-GB&lsquo;>References</span></b></a><span style=&lsquo;mso-bookmark:references&lsquo;><span
lang=EN-GB style=&lsquo;mso-ansi-language:EN-GB&lsquo;> </span></span><span lang=EN-GB
style=&lsquo;mso-ansi-language:EN-GB&lsquo;><o:p></o:p></span></p>
<p class=MsoNormal><span lang=EN-GB style=&lsquo;font-size:10.0pt;font-family:Arial;
mso-ansi-language:EN-GB&lsquo;>1 Macalpine I, Hunter R. The &quot;insanity&quot; of
King George III: a classic case of porphyria. BMJ 1966; 1: 65-71. <br>
2 Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR,
Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th
ed. New York: McGraw-Hill, 1989: 1305-65. <br>
3 Westfall RC. Isolation of porphobilinogen from the urine of a patient with
acute porphyria. Nature 1952; 170: 614-16. <br>
4 Brode WR, Pearson EG, Wyman GM. The relation between the absorption spectra
and chemical constitution of dyes. XXVII Cis-trans isomerization in indigo
dyes. </span><span style=&lsquo;font-size:10.0pt;font-family:Arial&lsquo;>J Am Chem Soc
1954; 76: 1034-36. <br>
</span><span lang=EN-GB style=&lsquo;font-size:10.0pt;font-family:Arial;mso-ansi-language:
EN-GB&lsquo;>5 Gehauf B, Goldenson J. Detection and estimation of nerve gases by
fluorescence reaction. </span><span style=&lsquo;font-size:10.0pt;font-family:Arial&lsquo;>Anal
Chem 1957; 29: 276-78. <br>
6 Guilbaut GB, Kramer DW. </span><span lang=EN-GB style=&lsquo;font-size:10.0pt;
font-family:Arial;mso-ansi-language:EN-GB&lsquo;>Resorufin butyrate and indoxyl
acetate as fluorogenic substrates for cholinesterases. Anal Chem 1965; 37:
120-23. <br>
7 Munk W. The life of Sir Henry Halford. London &amp; New York: Longmans, Green
&amp; Co, 1895. <br>
8 Halford H. Essays and orations, read and delivered at the Royal College of
Physicians. 2nd ed. London: John Murray, 1833. <br>
9 Macalpine I, Hunter R. Porphyria: a royal malady. London: British Medical
Association, 1968. <br>
10 Macalpine I, Hunter R. George III and the mad business. London: Allen Lane,
Penguin Press, 1969. <br>
11 Dean G. The porphyrias: a story of inheritance and environment. 2nd ed.
London: Pitman Medical, 1971. <br>
12 Wood WA, Gunsalus IC, Umbreit WW. Function of pyridoxal phosphate:
resolution and purification of the tryptophanase enzyme of Escherichia coli. J
Biol Chem 1947; 170: 313-21. <br>
13 Fordtran JS, Scroggie WB, Polter DE. Colonic absorption of tryptophan
metabolites in man. J Lab Clin Med 1964; 64: <br>
125-32. <br>
</span><span style=&lsquo;font-size:10.0pt;font-family:Arial&lsquo;>14 Marko AM, Reynolds
FB. </span><span lang=EN-GB style=&lsquo;font-size:10.0pt;font-family:Arial;
mso-ansi-language:EN-GB&lsquo;>A colorimetric method for measuring indican. Can J
Biochem Physiol 1960; 38: 253-62. <br>
15 Dealler SF, Hawkey PM, Millar MR. Enzymatic degradation of urinary indoxyl
sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple
urine bag syndrome. J Clin Microbiol 1988; 26: 2125-56. <br>
16 Rodnight R, McIlwain H. Indicanuria and psychosis of a pellagrin. <br>
</span><span lang=FR style=&lsquo;font-size:10.0pt;font-family:Arial;mso-ansi-language:
FR&lsquo;>J Ment Sci 1955; 101: 884-89. <br>
</span><span lang=EN-GB style=&lsquo;font-size:10.0pt;font-family:Arial;mso-ansi-language:
EN-GB&lsquo;>17 Jepson JB. Hartnup disease. In: Stanbury JB, Wyngaarden JB,
Fredrickson DS, eds. The metabolic basis of inherited disease. 3rd ed. New
York: McGraw-Hill, 1972: 1486-503. <br>
18 Rimington C. Indigoid pigments derived from a pathological urine. Biochem J
1946; 40: 669-74. <br>
19 Drummond KN, Michael AF, Ulstrom RA, Good RA. The blue diaper syndrome:
familial hypercalcemia with nephrocalcinosis and indicanuria. </span><span
style=&lsquo;font-size:10.0pt;font-family:Arial&lsquo;>Am J Med 1964; 37: 928-48. <br>
</span><span lang=EN-GB style=&lsquo;font-size:10.0pt;font-family:Arial;mso-ansi-language:
EN-GB&lsquo;>20 Ludwig GD, Epstein IS. A genetic study of two families having the
acute intermittent type of porphyria. </span><span style=&lsquo;font-size:10.0pt;
font-family:Arial&lsquo;>Ann Intern Med 1961; 55: 81-93. <br>
</span><span lang=EN-GB style=&lsquo;font-size:10.0pt;font-family:Arial;mso-ansi-language:
EN-GB&lsquo;>21 Price JM, Brown RR, Peters HA. Tryptophan metabolism in porphyria,
schizophrenia, and a variety of neurologic psychiatric diseases. </span><span
style=&lsquo;font-size:10.0pt;font-family:Arial&lsquo;>Neurology 1959; 9: 456-68. <br>
22 Sprince H. Indole metabolism in mental illness. Clin Chem 1961; 7: 203-30.

[Mic]

<A name=references><B>References</B></A><P><DIV class=jourcontentblack><P></P><P></P>1 Macalpine I, Hunter R. The "insanity" of King George III: a classic case of porphyria. BMJ 1966; 1: 65-71.<P></P><P></P>2 Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989: 1305-65.<P></P><P></P>3 Westfall RC. Isolation of porphobilinogen from the urine of a patient with acute porphyria. Nature 1952; 170: 614-16.<P></P><P></P>4 Brode WR, Pearson EG, Wyman GM. The relation between the absorption spectra and chemical constitution of dyes. XXVII Cis-trans isomerization in indigo dyes. J Am Chem Soc 1954; 76: 1034-36.<P></P><P></P>5 Gehauf B, Goldenson J. Detection and estimation of nerve gases by fluorescence reaction. Anal Chem 1957; 29: 276-78.<P></P><P></P>6 Guilbaut GB, Kramer DW. Resorufin butyrate and indoxyl acetate as fluorogenic substrates for cholinesterases. Anal Chem 1965; 37: 120-23.<P></P><P></P>7 Munk W. The life of Sir Henry Halford. London &amp; New York: Longmans, Green &amp; Co, 1895.<P></P><P></P>8 Halford H. Essays and orations, read and delivered at the Royal College of Physicians. 2nd ed. London: John Murray, 1833.<P></P><P></P>9 Macalpine I, Hunter R. Porphyria: a royal malady. London: British Medical Association, 1968.<P></P><P></P>10 Macalpine I, Hunter R. George III and the mad business. London: Allen Lane, Penguin Press, 1969.<P></P><P></P>11 Dean G. The porphyrias: a story of inheritance and environment. 2nd ed. London: Pitman Medical, 1971.<P></P><P></P>12 Wood WA, Gunsalus IC, Umbreit WW. Function of pyridoxal phosphate: resolution and purification of the tryptophanase enzyme of Escherichia coli. J Biol Chem 1947; 170: 313-21.<P></P><P></P>13 Fordtran JS, Scroggie WB, Polter DE. Colonic absorption of tryptophan metabolites in man. J Lab Clin Med 1964; 64: <BR>125-32.<P></P><P></P>14 Marko AM, Reynolds FB. A colorimetric method for measuring indican. Can J Biochem Physiol 1960; 38: 253-62.<P></P><P></P>15 Dealler SF, Hawkey PM, Millar MR. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J Clin Microbiol 1988; 26: 2125-56.<P></P><P></P>16 Rodnight R, McIlwain H. Indicanuria and psychosis of a pellagrin. J Ment Sci 1955; 101: 884-89.<P></P><P></P>17 Jepson JB. Hartnup disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease. 3rd ed. New York: McGraw-Hill, 1972: 1486-503.<P></P><P></P>18 Rimington C. Indigoid pigments derived from a pathological urine. Biochem J 1946; 40: 669-74.<P></P><P></P>19 Drummond KN, Michael AF, Ulstrom RA, Good RA. The blue diaper syndrome: familial hypercalcemia with nephrocalcinosis and indicanuria. Am J Med 1964; 37: 928-48.<P></P><P></P>20 Ludwig GD, Epstein IS. A genetic study of two families having the acute intermittent type of porphyria. Ann Intern Med 1961; 55: 81-93.<P></P><P></P>21 Price JM, Brown RR, Peters HA. Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic psychiatric diseases. Neurology 1959; 9: 456-68.<P></P><P></P>22 Sprince H. Indole metabolism in mental illness. Clin Chem 1961; 7: 203-30.

[Mic]

<TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0>
<TBODY>
<TR vAlign=top align=left>
<TD class=joursectitle width="100%"><A name=conclusion>Conclusion
</A></TD></TR></TBODY></TABLE>
<P>
<DIV class=jourcontentblack>
<P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s
constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice
with little or no effect". The doctor prescribed powdered Aloes socotrina (a
cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus,
the King probably had a condition that would lead to overproduction of urinary
indican. I have suggested a role for a bacterial sulphatase and shown a positive
result with conditions simulating either urinary tract infection or poor
hygiene. The amount of indoxyl sulphate in the test was within physiological
limits, although evaporation would actually increase concentrations. I also
suggest that Halford&lsquo;s observations of blue urine can be accommodated by a
background of acute intermittent porphyria, because severe and recurrent
constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The
madness of George III. London: Faber &amp; Faber, 1992). About a quarter way,
one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second
attendant argues purple. A similar exchange occurs in the penultimate scene. The
subsequent film script fixed upon blue alone in the final scene, and raised the
eyebrows of students of porphyria. <BR clear=all><A
href="#top"><IMG alt=Top
src="http://www.thelancet.com/llanimages/journal/top.gif" border=0></A><BR
clear=all></DIV>
<P>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=18597964#references"><B>References</B></A>

[Mic]

<TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0>
<TBODY>
<TR vAlign=top align=left>
<TD class=joursectitle width="100%"><A name=conclusion>Conclusion
</A></TD></TR></TBODY></TABLE><P>
<DIV class=jourcontentblack>
<P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s
constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice
with little or no effect". The doctor prescribed powdered Aloes socotrina (a
cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus,
the King probably had a condition that would lead to overproduction of urinary
indican. I have suggested a role for a bacterial sulphatase and shown a positive
result with conditions simulating either urinary tract infection or poor
hygiene. The amount of indoxyl sulphate in the test was within physiological
limits, although evaporation would actually increase concentrations. I also
suggest that Halford&lsquo;s observations of blue urine can be accommodated by a
background of acute intermittent porphyria, because severe and recurrent
constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The
madness of George III. London: Faber &amp; Faber, 1992). About a quarter way,
one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second
attendant argues purple. A similar exchange occurs in the penultimate scene. The
subsequent film script fixed upon blue alone in the final scene, and raised the
eyebrows of students of porphyria. <BR clear=all><A
href="http://www.thelancet.com/search/search.isa#top"><IMG alt=Top
src="http://www.thelancet.com/llanimages/journal/top.gif" border=0></A><BR
clear=all></DIV>

[Mic]

<TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=conclusion>Conclusion </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice with little or no effect". The doctor prescribed powdered Aloes socotrina (a cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus, the King probably had a condition that would lead to overproduction of urinary indican. I have suggested a role for a bacterial sulphatase and shown a positive result with conditions simulating either urinary tract infection or poor hygiene. The amount of indoxyl sulphate in the test was within physiological limits, although evaporation would actually increase concentrations. I also suggest that Halford&lsquo;s observations of blue urine can be accommodated by a background of acute intermittent porphyria, because severe and recurrent constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The
madness of George III. London: Faber &amp; Faber, 1992). About a quarter way,
one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second attendant argues purple. A similar exchange occurs in the penultimate scene. The subsequent film script fixed upon blue alone in the final scene, and raised the eyebrows of students of porphyria. <BR clear=all><A href="http://www.thelancet.com/search/search.isa#top"><IMG alt=Top src="http://www.thelancet.com/llanimages/journal/top.gif" border=0></A><BR clear=all></DIV>

[Mic]

<TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursubtitle width="100%">Urinary indican </TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>The normal bacterial flora of the colon includes species with tryptophanase, which catalyses the formation of indole, pyruvic acid, and ammonia from dietary tryptophan.<SUP>12</SUP> Indole is rapidly absorbed from the colon.<SUP>13 </SUP>The sequential biochemical steps in intestinal bacteria, liver, and urinary bacteria, leading to indoxyl in the urine and thence by non-enzymic oxidative dimerisation to indigo blue are summarised in figure 2. Excretion of indoxyl sulphate (indican) up to 140 mg per day is not uncommon in healthy adults.<SUP>14</SUP> The bag attached to a urinary catheter sometimes develops a purple colouration, which is due to excretion of indican, increased presentation time to adventitious bacteria with sulphatase, and an affinity of the plastics for indigoid pigments.<SUP>15</SUP>
<P></P>Some nutritional abnormalities and disease states are attended with substantial increases in indican. For example, Rodnight and McIlwain<SUP>16</SUP> reported that a young boy with pellegra and psychotic symptoms had a six-fold increase of indican in his urine before the condition was resolved with dietary supplements of nicotinamide. Patients with Hartnup disease, caused by a congenital abnormality in the absorption of some minoacids
including tryptophan, may produce 400 mg/day of indican.<SUP>17</SUP> A case of sprue was marked by increased concentrations of indole derivatives in the urine.18 A familial disease in which hypercalcaemia and nephrocalcinosis are associated with decreased transport of intestinal tryptophan is accompanied by excessive indole production and abnormal indican concentrations in the urine.<SUP>19</SUP> </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursubtitle width="100%">Indican and porphyria</TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack>
<P></P>At least two reports on acute intermittent porphyria may be of immediate
relevance. Ludwig and Epstein20 studied a family with an especially high degree
of penetrance, and observed that some of the family members showed increased
urinary indican even in remission. Price and colleagues<SUP>21</SUP> observed an abnormal response to tryptophan loading in some of their porphyria patients. It is noteworthy that the sporadic reports of increased concentrations of various indole derivatives in the urines of mentally ill patients do not show a direct relation with mental disturbance. Rather, indicanuria is most often associated with bowel stasis and influenced by dietary protein composition and intestinal bacteria.<SUP>22</SUP> <BR clear=all></DIV><P><TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=conclusion>Conclusion </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice with little or no effect". The doctor prescribed powdered Aloes socotrina (a cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus, the King probably had a condition that would lead to overproduction of urinary indican. I have suggested a role for a bacterial sulphatase and shown a positive result with conditions simulating either urinary tract infection or poor hygiene. The amount of indoxyl sulphate in the test was within physiological limits, although evaporation would actually increase concentrations. I also suggest that Halford&lsquo;s observations of blue urine can be accommodated by a background of acute intermittent porphyria, because severe and recurrent constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The madness of George III. London: Faber &amp; Faber, 1992). About a quarter way, one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second attendant argues purple. A similar exchange occurs in the penultimate scene. The subsequent film script fixed upon blue alone in the final scene, and raised the eyebrows of students of porphyria.</DIV>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=18597964#references"><B>References</B></A>

[Mic]

<TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursubtitle width="100%">Urinary indican </TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>The normal bacterial flora of the colon includes species with tryptophanase, which catalyses the formation of indole, pyruvic acid, and ammonia from dietary tryptophan.<SUP>12</SUP> Indole is rapidly absorbed from the colon.<SUP>13 </SUP>The sequential biochemical steps in intestinal bacteria, liver, and urinary bacteria, leading to indoxyl in the urine and thence by non-enzymic oxidative dimerisation to indigo blue are summarised in figure 2. Excretion of indoxyl sulphate (indican) up to 140 mg per day is not uncommon in healthy adults.<SUP>14</SUP> The bag attached to a urinary catheter sometimes develops a purple colouration, which is due to excretion of indican, increased presentation time to adventitious bacteria with sulphatase, and an affinity of the plastics for indigoid pigments.<SUP>15</SUP>
<P></P>Some nutritional abnormalities and disease states are attended with substantial increases in indican. For example, Rodnight and McIlwain<SUP>16</SUP> reported that a young boy with pellegra and psychotic symptoms had a six-fold increase of indican in his urine before the condition was resolved with dietary supplements of nicotinamide. Patients with Hartnup disease, caused by a congenital abnormality in the absorption of some aminoacids including tryptophan, may produce 400 mg/day of indican.<SUP>17</SUP> A case of sprue was marked by increased concentrations of indole derivatives in the urine.18 A familial disease in which hypercalcaemia and nephrocalcinosis are associated with decreased transport of intestinal tryptophan is accompanied by excessive indole production and abnormal indican concentrations in the urine.<SUP>19</SUP> </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursubtitle width="100%">Indican and porphyria</TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack>
<P></P>At least two reports on acute intermittent porphyria may be of immediate relevance. Ludwig and Epstein<SUP>20</SUP> studied a family with an especially high degree of penetrance, and observed that some of the family members showed increased urinary indican even in remission. Price and colleagues<SUP>21</SUP> observed an abnormal response to tryptophan loading in some of their porphyria patients. It is noteworthy that the sporadic reports of increased concentrations of various indole derivatives in the urines of mentally ill patients do not show a direct relation with mental disturbance. Rather, indicanuria is most often associated with bowel stasis and influenced by dietary protein composition and intestinal bacteria.<SUP>22</SUP> <BR clear=all></DIV><P><TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=conclusion>Conclusion </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice with little or no effect". The doctor prescribed powdered Aloes socotrina (a cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus, the King probably had a condition that would lead to overproduction of urinary indican. I have suggested a role for a bacterial sulphatase and shown a positive result with conditions simulating either urinary tract infection or poor hygiene. The amount of indoxyl sulphate in the test was within physiological limits, although evaporation would actually increase concentrations. I also suggest that Halford&lsquo;s observations of blue urine can be accommodated by a background of acute intermittent porphyria, because severe and recurrent constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The madness of George III. London: Faber &amp; Faber, 1992). About a quarter way, one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second attendant argues purple. A similar exchange occurs in the penultimate scene. The subsequent film script fixed upon blue alone in the final scene, and raised the eyebrows of students of porphyria.</DIV>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=809595778#conclusion">Conclusion</A>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=18597964#references"><B>References</B></A>

[Mic]

<TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursubtitle width="100%">Urinary indican </TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>The normal bacterial flora of the colon includes species with tryptophanase, which catalyses the formation of indole, pyruvic acid, and ammonia from dietary tryptophan.<SUP>12</SUP> Indole is rapidly absorbed from the colon.<SUP>13 </SUP>The sequential biochemical steps in intestinal bacteria, liver, and urinary bacteria, leading to indoxyl in the urine and thence by non-enzymic oxidative dimerisation to indigo blue are summarised in figure 2. Excretion of indoxyl sulphate (indican) up to 140 mg per day is not uncommon in healthy adults.<SUP>14</SUP> The bag attached to a urinary catheter sometimes develops a purple colouration, which is due to excretion of indican, increased presentation time to adventitious bacteria with sulphatase, and an affinity of the plastics for indigoid pigments.<SUP>15</SUP>
<P></P>Some nutritional abnormalities and disease states are attended with substantial increases in indican. For example, Rodnight and McIlwain<SUP>16</SUP> reported that a young boy with pellegra and psychotic symptoms had a six-fold increase of indican in his urine before the condition was resolved with dietary supplements of nicotinamide. Patients with Hartnup disease, caused by a congenital abnormality in the absorption of some aminoacids including tryptophan, may produce 400 mg/day of indican.<SUP>17</SUP> A case of sprue was marked by increased concentrations of indole derivatives in the urine.18 A familial disease in which hypercalcaemia and nephrocalcinosis are associated with decreased transport of intestinal tryptophan is accompanied by excessive indole production and abnormal indican concentrations in the urine.<SUP>19</SUP> </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursubtitle width="100%">Indican and porphyria</TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>At least two reports on acute intermittent porphyria may be of immediate relevance. Ludwig and Epstein<SUP>20</SUP> studied a family with an especially high degree of penetrance, and observed that some of the family members showed increased urinary indican even in remission. Price and colleagues<SUP>21</SUP> observed an abnormal response to tryptophan loading in some of their porphyria patients. It is noteworthy that the sporadic reports of increased concentrations of various indole derivatives in the urines of mentally ill patients do not show a direct relation with mental disturbance. Rather, indicanuria is most often associated with bowel stasis and influenced by dietary protein composition and intestinal bacteria.<SUP>22</SUP> <BR clear=all></DIV><P><TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=conclusion>Conclusion </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice with little or no effect". The doctor prescribed powdered Aloes socotrina (a cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus, the King probably had a condition that would lead to overproduction of urinary indican. I have suggested a role for a bacterial sulphatase and shown a positive result with conditions simulating either urinary tract infection or poor hygiene. The amount of indoxyl sulphate in the test was within physiological limits, although evaporation would actually increase concentrations. I also suggest that Halford&lsquo;s observations of blue urine can be accommodated by a background of acute intermittent porphyria, because severe and recurrent constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The madness of George III. London: Faber &amp; Faber, 1992). About a quarter way, one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second attendant argues purple. A similar exchange occurs in the penultimate scene. The subsequent film script fixed upon blue alone in the final scene, and raised the eyebrows of students of porphyria.</DIV>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=18597964#references"><B>References</B></A>

[Mic]

<TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=theillnessofkinggeorge>The illness of King George </A></TD></TR></TBODY></TABLE><P>
<DIV class=jourcontentblack><P></P>Sir Henry Halford (1766-1844) was created a baronet by King George III. He had been summoned to attend Princess Amelia, who died in 1810, and was then retained by the King, who was 72 years old. Halford spent almost half the year of 1811 at Windsor Castle where he joined in sympathetic consultations with Dr Matthew Baille and Dr William Heberden and had an uneasy relationship with Dr John Willis and Dr Robert Willis, who were in favour of more restraining treatments for the King.<SUP>7</SUP> Halford was not involved with any of the previous eight episodes of serious illness, the first of which occurred in the King&lsquo;s third decade. <P></P><IMG src="http://image.thelancet.com/lancet/issues/vol347no9018/history1811/961508(2).gif" align=right></IMG> <P></P><P></P><ESFIGURE><B>Figure 2: The formation of indigo blue from dietary tryptophan</B></ESFIGURE><P></P><ESFIGURE><B>Enzymically catalysed steps occur in intestinal bacteria, liver, and urinary bacteria, in this sequence. The final chemical reaction is a non-enzymic oxidative dimerisation.</B> </ESFIGURE><P></P>Halford speculated that King George&lsquo;s illness was primarily due to ageing, and that the medical crises were associated with "climacterics" occurring at intervals with mystical multiples of seven.<SUP>8</SUP> Subsequent studies, most notably by Ray in 1855 and Guttmacher in 1941, did not advance any real understanding of the King&lsquo;s illness because they embraced only selected aspects of the records and presented the case for manic depressive psychosis by excluding all but mental symptoms.<SUP>1</SUP> <P></P>Macalpine and Hunter were the first to address the well-documented physical signs and symptoms as well as the psychotic episodes. Thus, the crises involving colicky abdominal pain accompanied by constipation and vomiting, paralysis, peripheral neuritis, tachycardia, sweating, brown or red urine, insomnia, delirium, the exacerbation of symptoms due to infections (caused by cupping), and the absence of any permanent neurological deficit after each crisis were noted and reasonably seen as acute intermittent porphyria.<SUP>1</SUP> I believe that the age of onset of first symptoms, the dynamics of all severe episodes, and the deleterious effects of some of the medications, all exemplified by modern examples of acute intermittent porphyria,<SUP>2</SUP> should also be added to that list. <P></P>Macalpine and Hunter subsequently modified their original working hypothesis to variegate porphyria, primarily to accommodate skin sensitivity, for which the evidence was meagre.<SUP>9,10</SUP> Objection to their retrospective categorical diagnosis and to specifics of variegate porphyria, and a preoccupation with prevalence rates of the disorder in the general population, became the thrusts of subsequent criticisms, which were often vehement and remarkably uninterested in the total medical picture of King George III (see for example Dean11 and references therein). Some sort of toxic psychosis is indicated within which a metabolic disorder such as acute intermittent porphyria, which will accommodate all of the neurological symptoms as well as the exacerbation factors,<SUP>2</SUP> remains a strong possibility. Indeed, Rimington (quoted in Dean,<SUP>11</SUP>p 168) opined that there was "so much in the records being suggestive of porphyria and difficult to explain on any other basis". But what about the blue urine? </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursubtitle width="100%">Urinary indican </TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>The normal bacterial flora of the colon includes species with tryptophanase, which catalyses the formation of indole, pyruvic acid, and ammonia from dietary tryptophan.<SUP>12</SUP> Indole is rapidly absorbed from the colon.<SUP>13 </SUP>The sequential biochemical steps in intestinal bacteria, liver, and urinary bacteria, leading to indoxyl in the urine and thence by non-enzymic oxidative dimerisation to indigo blue are summarised in figure 2. Excretion of indoxyl sulphate (indican) up to 140 mg per day is not uncommon in healthy adults.<SUP>14</SUP> The bag attached to a urinary catheter sometimes develops a purple colouration, which is due to excretion of indican, increased presentation time to adventitious bacteria with sulphatase, and an affinity of the plastics for indigoid pigments.<SUP>15</SUP>
<P></P>Some nutritional abnormalities and disease states are attended with substantial increases in indican. For example, Rodnight and McIlwain<SUP>16</SUP> reported that a young boy with pellegra and psychotic symptoms had a six-fold increase of indican in his urine before the condition was resolved with dietary supplements of nicotinamide. Patients with Hartnup disease, caused by a congenital abnormality in the absorption of some aminoacids including tryptophan, may produce 400 mg/day of indican.<SUP>17</SUP> A case of sprue was marked by increased concentrations of indole derivatives in the urine.18 A familial disease in which hypercalcaemia and nephrocalcinosis are associated with decreased transport of intestinal tryptophan is accompanied by excessive indole production and abnormal indican concentrations in the urine.<SUP>19</SUP> </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursubtitle width="100%">Indican and porphyria</TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>At least two reports on acute intermittent porphyria may be of immediate relevance. Ludwig and Epstein<SUP>20</SUP> studied a family with an especially high degree of penetrance, and observed that some of the family members showed increased urinary indican even in remission. Price and colleagues<SUP>21</SUP> observed an abnormal response to tryptophan loading in some of their porphyria patients. It is noteworthy that the sporadic reports of increased concentrations of various indole derivatives in the urines of mentally ill patients do not show a direct relation with mental disturbance. Rather, indicanuria is most often associated with bowel stasis and influenced by dietary protein composition and intestinal bacteria.<SUP>22</SUP> <BR clear=all></DIV><P><TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=conclusion>Conclusion </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice with little or no effect". The doctor prescribed powdered Aloes socotrina (a cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus, the King probably had a condition that would lead to overproduction of urinary indican. I have suggested a role for a bacterial sulphatase and shown a positive result with conditions simulating either urinary tract infection or poor hygiene. The amount of indoxyl sulphate in the test was within physiological limits, although evaporation would actually increase concentrations. I also suggest that Halford&lsquo;s observations of blue urine can be accommodated by a background of acute intermittent porphyria, because severe and recurrent constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The madness of George III. London: Faber &amp; Faber, 1992). About a quarter way, one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second attendant argues purple. A similar exchange occurs in the penultimate scene. The subsequent film script fixed upon blue alone in the final scene, and raised the eyebrows of students of porphyria.</DIV>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=18597964#references"><B>References</B></A>

[Mic]

<TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=theillnessofkinggeorge>The illness of King George </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford (1766-1844) was created a baronet by King George III. He had been summoned to attend Princess Amelia, who died in 1810, and was then retained by the King, who was 72 years old. Halford spent almost half the year of 1811 at Windsor Castle where he joined in sympathetic consultations with Dr Matthew Baille and Dr William Heberden and had an uneasy relationship with Dr John Willis and Dr Robert Willis, who were in favour of more restraining treatments for the King.<SUP>7</SUP> Halford was not involved with any of the previous eight episodes of serious illness, the first of which occurred in the King&lsquo;s third decade. <P></P><IMG src="http://image.thelancet.com/lancet/issues/vol347no9018/history1811/961508(2).gif" align=right></IMG> <P></P><P></P><ESFIGURE><B>Figure 2: The formation of indigo blue from dietary tryptophan</B></ESFIGURE><P></P><ESFIGURE><B>Enzymically catalysed steps occur in intestinal bacteria, liver, and urinary bacteria, in this sequence. The final chemical reaction is a non-enzymic oxidative dimerisation.</B> </ESFIGURE><P></P>Halford speculated that King George&lsquo;s illness was primarily due to ageing, and that the medical crises were associated with "climacterics" occurring at intervals with mystical multiples of seven.<SUP>8</SUP> Subsequent studies, most notably by Ray in 1855 and Guttmacher in 1941, did not advance any real understanding of the King&lsquo;s illness because they embraced only selected aspects of the records and presented the case for manic depressive psychosis by excluding all but mental symptoms.<SUP>1</SUP> <P></P>Macalpine and Hunter were the first to address the well-documented physical signs and symptoms as well as the psychotic episodes. Thus, the crises involving colicky abdominal pain accompanied by constipation and vomiting, paralysis, peripheral neuritis, tachycardia, sweating, brown or red urine, insomnia, delirium, the exacerbation of symptoms due to infections (caused by cupping), and the absence of any permanent neurological deficit after each crisis were noted and reasonably seen as acute intermittent porphyria.<SUP>1</SUP> I believe that the age of onset of first symptoms, the dynamics of all severe episodes, and the deleterious effects of some of the medications, all exemplified by modern examples of acute intermittent porphyria,<SUP>2</SUP> should also be added to that list. <P></P>Macalpine and Hunter subsequently modified their original working hypothesis to variegate porphyria, primarily to accommodate skin sensitivity, for which the evidence was meagre.<SUP>9,10</SUP> Objection to their retrospective categorical diagnosis and to specifics of variegate porphyria, and a preoccupation with prevalence rates of the disorder in the general population, became the thrusts of subsequent criticisms, which were often vehement and remarkably uninterested in the total medical picture of King George III (see for example Dean11 and references therein). Some sort of toxic psychosis is indicated within which a metabolic disorder such as acute intermittent porphyria, which will accommodate all of the neurological symptoms as well as the exacerbation factors,<SUP>2</SUP> remains a strong possibility. Indeed, Rimington (quoted in Dean,<SUP>11</SUP>p 168) opined that there was "so much in the records being suggestive of porphyria and difficult to explain on any other basis". But what about the blue urine? </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursubtitle width="100%">Urinary indican </TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>The normal bacterial flora of the colon includes species with tryptophanase, which catalyses the formation of indole, pyruvic acid, and ammonia from dietary tryptophan.<SUP>12</SUP> Indole is rapidly absorbed from the colon.<SUP>13 </SUP>The sequential biochemical steps in intestinal bacteria, liver, and urinary bacteria, leading to indoxyl in the urine and thence by non-enzymic oxidative dimerisation to indigo blue are summarised in figure 2. Excretion of indoxyl sulphate (indican) up to 140 mg per day is not uncommon in healthy adults.<SUP>14</SUP> The bag attached to a urinary catheter sometimes develops a purple colouration, which is due to excretion of indican, increased presentation time to adventitious bacteria with sulphatase, and an affinity of the plastics for indigoid pigments.<SUP>15</SUP>
<P></P>Some nutritional abnormalities and disease states are attended with substantial increases in indican. For example, Rodnight and McIlwain<SUP>16</SUP> reported that a young boy with pellegra and psychotic symptoms had a six-fold increase of indican in his urine before the condition was resolved with dietary supplements of nicotinamide. Patients with Hartnup disease, caused by a congenital abnormality in the absorption of some aminoacids including tryptophan, may produce 400 mg/day of indican.<SUP>17</SUP> A case of sprue was marked by increased concentrations of indole derivatives in the urine.18 A familial disease in which hypercalcaemia and nephrocalcinosis are associated with decreased transport of intestinal tryptophan is accompanied by excessive indole production and abnormal indican concentrations in the urine.<SUP>19</SUP> </DIV><P><TABLE class=joursubtitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursubtitle width="100%">Indican and porphyria</TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>At least two reports on acute intermittent porphyria may be of immediate relevance. Ludwig and Epstein<SUP>20</SUP> studied a family with an especially high degree of penetrance, and observed that some of the family members showed increased urinary indican even in remission. Price and colleagues<SUP>21</SUP> observed an abnormal response to tryptophan loading in some of their porphyria patients. It is noteworthy that the sporadic reports of increased concentrations of various indole derivatives in the urines of mentally ill patients do not show a direct relation with mental disturbance. Rather, indicanuria is most often associated with bowel stasis and influenced by dietary protein composition and intestinal bacteria.<SUP>22</SUP> <BR clear=all></DIV><P><TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0> <TBODY> <TR vAlign=top align=left> <TD class=joursectitle width="100%"><A name=conclusion>Conclusion </A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>Sir Henry Halford&lsquo;s bulletin of Jan 6, 1811, euphemised King George&lsquo;s constipation: "2·5 hours sleep after midnight . . . up to the w. closet twice with little or no effect". The doctor prescribed powdered Aloes socotrina (a cathartic) and extract of Taraxacum officinale (a laxative and diuretic). Thus, the King probably had a condition that would lead to overproduction of urinary indican. I have suggested a role for a bacterial sulphatase and shown a positive result with conditions simulating either urinary tract infection or poor hygiene. The amount of indoxyl sulphate in the test was within physiological limits, although evaporation would actually increase concentrations. I also suggest that Halford&lsquo;s observations of blue urine can be accommodated by a background of acute intermittent porphyria, because severe and recurrent constipation is a hallmark of that disease.
<P></P>The incentive for this study came from the play by Alan Bennett (The madness of George III. London: Faber &amp; Faber, 1992). About a quarter way, one of the King&lsquo;s pages remarks upon His Majesty&lsquo;s urine being blue and a second attendant argues purple. A similar exchange occurs in the penultimate scene. The subsequent film script fixed upon blue alone in the final scene, and raised the eyebrows of students of porphyria.</DIV>
<A href="http://www.hashimotothyreoiditis.de/cgi-bin/ht-forum.exe?VIEWID=18597964#references"><B>References</B></A>

[Mic]

<BODY bgColor=#ffffff><DIV><FONT face=Arial size=2></FONT><FONT face=Arial size=2><TABLE height=30 cellSpacing=0 cellPadding=0 width="100%" bgColor=#999999 border=0><TBODY><TR><TD><IMG height=1 src="http://www.thelancet.com/llanimages/navigation/1px_trans.gif" width=300></TD><TD align=right><IMG height=20 src="http://www.thelancet.com/llanimages/navigation/tlpg.gif" width=340><IMG height=1 src="http://www.thelancet.com/llanimages/navigation/1px_trans.gif" width=8></TD></TR></TBODY></TABLE><TABLE height=24 cellSpacing=0 cellPadding=0 width="100%" bgColor=#006699 border=0><TBODY><TR><TD bgColor=#006699 colSpan=3><IMG height=16 src="http://www.thelancet.com/llanimages/navigation/1px_trans.gif" width="100%"></TD></TR><TR><TD vAlign=top align=left width="1%" bgColor=#006699 height=25><A href="http://www.thelancet.com/home"><IMG height=24 alt="THE LANCET" src="http://www.thelancet.com/llanimages/navigation/logo.gif" width=170 border=0></A></TD></TR></TBODY></TABLE><TABLE cellSpacing=0 cellPadding=0 border=0><TBODY><TR><TD bg="#FFFFFF"><IMG height=21 src="http://www.thelancet.com/llanimages/navigation/1px_trans.gif" width=10></TD><TD class=drill><FONT face=verdana size=1><A class=sidenav>Volume&nbsp;347,&nbsp;Number&nbsp;9018&nbsp;&nbsp; &nbsp;&nbsp;29&nbsp;June&nbsp;1996</A></FONT></TD><TD bg="#FFFFFF"><IMG height=21 src="http://www.thelancet.com/llanimages/navigation/1px_trans.gif" width=30></TD></TR></TBODY></TABLE><BR><ELSE><TABLE cellSpacing=0 cellPadding=0 width="100%"><TBODY><TR colspan="2"><TD height=5><DIV><FONT size=2></FONT>&nbsp;</DIV><DIV><FONT size=2></FONT>&nbsp;</DIV></TD></TR><TR><TD width=15 bgColor=#006699><A name=top><IMG height=11 alt="" src="http://www.thelancet.com/llanimages/navigation/1px_trans.gif" width=15 border=0></A></TD><TD class=joursecthead width="100%">&nbsp;<B>Department of medical history</B></A></TD></TR></TBODY></TABLE><BR><DIV class=jourcontentblack></DIV><TABLE class=jourtitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=jourtitle width="100%"><B>King George III&lsquo;s urine and indigo blue</B></TD></TR></TBODY></TABLE><DIV class=jourcontentblack><P><I>Wilfred Niels Arnold </I><P></P><I>Lancet</I> 1996; <B>347:</B> 1811-13<P></P><P><HR><I><B>Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas, 66160-7421, USA </B>(Prof W N Arnold PhD)</I><P></P><A href="#rationale">Rationale</A><BR><A href="#experiments">Experiments</A><BR><A href="#theillnessofkinggeorge">The illness of King George </A><BR><A href="#conclusion">Conclusion</A><BR><A href="#references">References </A><BR><P></P>Attending physicians to King George III (1738-1820) recorded unusual colours in his urine on at least four occasions.<SUP>1</SUP> Sir George Baker, on Oct 18, 1788, wrote in his diary that the urine was "bilious" (golden brown) and on Aug 26, 1819, Dr Matthew Baille and Dr John Willis reported on "bloody water". Those departures from the normal yellow of urochrome can be explained with a 20th century hypothesis1--namely, that the king had a form of porphyria, in which excessive amounts of 5-aminolevulinic acid and porphobilinogen are excreted during medical crises. These compounds are colourless but can cause pigmentation of the urine upon ageing.<SUP>2</SUP> The formation of brown, reddish-brown, or purple hue is due to non-enzymic reactions yielding mixtures of porphyrins and other pigments such as porphobilin.<SUP>3</SUP> The final colour of acute porphyric urine depends on initial concentrations of the compounds undergoing polymerisation, light intensity, and storage time. <P></P>On the other hand, two reports by Sir Henry Halford about <I>blue</I> pigments were listed but not explained by Macalpine and Hunter.<SUP>1</SUP> On Jan 14, 1812, specimens containing 8 and 9 fluid ounces of "bluish" urine were registered on behalf of the King. In the bulletin of Jan 6, 1811, Sir Henry wrote, "The water is of a deeper colour--and leaves a pale blue ring upon the glass near the upper surface". Concurrent documentation showed that the patient was suffering from one of many intractable bouts of constipation and vomiting. Clearly, the blue compound was sparingly soluble and, because the precipitate developed near the surface, I reasoned that oxygen was involved. The hue pointed to indole chemistry. </DIV><P><TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursectitle width="100%"><A name=rationale>Rationale</A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>The following working hypothesis may explain the early 19th century observations. Because the patient was constipated, putrefaction during stasis of the bowel led to indole formation from dietary tryptophan by the normal intestinal flora. Some indole was absorbed into the blood stream and converted in the liver first to indoxyl and then to the sulphate ester. The colourless, water-soluble indoxyl sulphate (metabolic indican in the older published research) was excreted in the urine. In the presence of a sulphatase of bacterial origin, either from a urinary tract infection or as an environmental contaminant of the chamber pot, indoxyl was slowly released by hydrolysis and oxidatively dimerised into indigo blue, which precipitated on the porcelain. <BR clear=all><A href="#top"><IMG alt=Top src="http://www.thelancet.com/llanimages/journal/top.gif" border=0></A><BR clear=all></DIV>

[Mic]

<TABLE class=joursectitle cellSpacing=0 cellPadding=0 width="100%" border=0><TBODY><TR vAlign=top align=left><TD class=joursectitle width="100%"><A name=experiments>Experiments</A></TD></TR></TBODY></TABLE><P><DIV class=jourcontentblack><P></P>I have demonstrated a model for the latter steps in laboratory experiments. 1 mL samples of normal urine, with or without fortification by indoxyl sulphate<BR>(1 mg/mL), were placed in porcelain crucibles (25 mm diameter at the top). Some pots were inoculated with<BR>0·1 mL of a suspension (about 10<SUP>10</SUP> colony forming units/mL) of <I>Providencia stuartii</I>cells, which had been flushed from the surface of an agar slant with fresh urine. Controls were samples of normal urine, and of urine plus indoxyl sulphate, that were not inoculated. The crucibles were placed on moist paper towels, in a covered jar, and the mixtures were incubated overnight at room temperature (23°C). The samples that contained both indoxyl sulphate and P stuartii developed a dark blue pigmentation (figure 1). The blue ring on the crucible itself was more obvious after the urine had been removed with a syringe. This pigment was insoluble in water but dissolved in chloroform and displayed an absorption maximum at 604 nm, consistent with indigo blue
(indigotin).<SUP>4</SUP><P></P>The formation of blue pigment depended on incubation time, and on the initial concentrations of indoxyl sulphate and of bacterial suspension. A bluish tinge was apparent after 1 to 2 days, even when only 25% of the indoxyl sulphate and 10% of the bacterial inoculum were used. The blue colour was more intense and developed faster if the urine was initially adjusted to pH 7·0 than if it were adjusted to pH 6·0 or lower; this accords with the chemistry of indigo blue formation, rather than that of indigo white or indigo red.<SUP>5,6</SUP><P></P><SUP></SUP><P></P><ESFIGURE><B>Figure 1: Simulation of Sir Henry Halford&lsquo;s observations of 1811</B> </ESFIGURE><P></P><ESFIGURE><B>"The water is of a deeper colour" (left) . . . "and leaves a pale blue ring upon the glass" (right). Controls (left vessel of each panel) are included. The liquid from the vessel on the far right has been removed to reveal the blue ring. <IMG src="http://image.thelancet.com/lancet/issues/vol347no9018/history1811/961508arnold.gif" align=right></IMG> </B></ESFIGURE><P></P><I>P stuartii</I> was chosen as the test microorganism because it has been associated with urinary tract infections and aryl sulphatase activity (the species was named after C A Stuart, bacteriologist of Providence, Rhode Island, USA, and has no connection to the Royal House of Stuart). Of the eight isolates of this organism (supplied by William Bartholomew and Rebecca Horvat, University of Kansas, and Harry Mobley, University of Maryland), two contained enough aryl sulphatase to be useful in my experiments. Importantly, they also contained urease, which promoted alkalisation of the incubation mixtures and the yield of indigo blue. I also obtained a positive result by setting up the porcelain crucibles with 0·1 mL suspensions of <I>P stuartii</I>, drying them overnight at room temperature, and then adding the urine with indoxyl sulphate. <I>P stuartii</I> is not essential to the working hypothesis; any species with adequate aryl sulphatase and urease activities, and a tolerance of human urine, would perform similarly and generate a blue ring. The shape and material of the vessel, together with the kinetics of the chemical reactions, determine the disposition of the indigo and the extent of a "Halford blue ring".

[Mic]

<A name=references><B>References</B></A><P><DIV class=jourcontentblack><P></P><P></P>1 Macalpine I, Hunter R. The "insanity" of King George III: a classic case of porphyria. BMJ 1966; 1: 65-71.<P></P><P></P>2 Kappas A, Sassa S, Galbraith RA, Nordmann Y. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989: 1305-65.<P></P><P></P>3 Westfall RC. Isolation of porphobilinogen from the urine of a patient with acute porphyria. Nature 1952; 170: 614-16.<P></P><P></P>4 Brode WR, Pearson EG, Wyman GM. The relation between the absorption spectra and chemical constitution of dyes. XXVII Cis-trans isomerization in indigo dyes. J Am Chem Soc 1954; 76: 1034-36.<P></P><P></P>5 Gehauf B, Goldenson J. Detection and estimation of nerve gases by fluorescence reaction. Anal Chem 1957; 29: 276-78.<P></P><P></P>6 Guilbaut GB, Kramer DW. Resorufin butyrate and indoxyl acetate as fluorogenic substrates for cholinesterases. Anal Chem 1965; 37: 120-23.<P></P><P></P>7 Munk W. The life of Sir Henry Halford. London &amp; New York: Longmans, Green &amp; Co, 1895.<P></P><P></P>8 Halford H. Essays and orations, read and delivered at the Royal College of Physicians. 2nd ed. London: John Murray, 1833.<P></P><P></P>9 Macalpine I, Hunter R. Porphyria: a royal malady. London: British Medical Association, 1968.<P></P><P></P>10 Macalpine I, Hunter R. George III and the mad business. London: Allen Lane, Penguin Press, 1969.<P></P><P></P>11 Dean G. The porphyrias: a story of inheritance and environment. 2nd ed. London: Pitman Medical, 1971.<P></P><P></P>12 Wood WA, Gunsalus IC, Umbreit WW. Function of pyridoxal phosphate: resolution and purification of the tryptophanase enzyme of Escherichia coli. J Biol Chem 1947; 170: 313-21.<P></P><P></P>13 Fordtran JS, Scroggie WB, Polter DE. Colonic absorption of tryptophan metabolites in man. J Lab Clin Med 1964; 64: <BR>125-32.<P></P><P></P>14 Marko AM, Reynolds FB. A colorimetric method for measuring indican. Can J Biochem Physiol 1960; 38: 253-62.<P></P><P></P>15 Dealler SF, Hawkey PM, Millar MR. Enzymatic degradation of urinary indoxyl sulfate by Providencia stuartii and Klebsiella pneumoniae causes the purple urine bag syndrome. J Clin Microbiol 1988; 26: 2125-56.<P></P><P></P>16 Rodnight R, McIlwain H. Indicanuria and psychosis of a pellagrin. J Ment Sci 1955; 101: 884-89.<P></P><P></P>17 Jepson JB. Hartnup disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease. 3rd ed. New York: McGraw-Hill, 1972: 1486-503.<P></P><P></P>18 Rimington C. Indigoid pigments derived from a pathological urine. Biochem J 1946; 40: 669-74.<P></P><P></P>19 Drummond KN, Michael AF, Ulstrom RA, Good RA. The blue diaper syndrome: familial hypercalcemia with nephrocalcinosis and indicanuria. Am J Med 1964; 37: 928-48.<P></P><P></P>20 Ludwig GD, Epstein IS. A genetic study of two families having the acute intermittent type of porphyria. Ann Intern Med 1961; 55: 81-93.<P></P><P></P>21 Price JM, Brown RR, Peters HA. Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic psychiatric diseases. Neurology 1959; 9: 456-68.<P></P><P></P>22 Sprince H. Indole metabolism in mental illness. Clin Chem 1961; 7: 203-30.

[Mic]

<html>
<HEAD>
<LINK href="http://www.rote-liste.de/Online/gliederung/praepstyle.css" REL="stylesheet" TYPE="text/css">
</HEAD>
<body>
<table width="100%" border=0 cellpadding=0 cellspacing=0>
<tr><td>&nbsp;</td><td>&nbsp;</td></tr>
<tr>
<td align="right">
<a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise</a>
</td>
<td>&nbsp;</td>
</tr>
</table>
<table width="100%" border="0">
<tr>

<td valign="top">
<table border="0">
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/01/viewHauptgruppe"><b>01.</a></td><td valign="top">Abmagerungsmittel/Appetitz&uuml;gler</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/02/viewHauptgruppe"><b>02.</a></td><td valign="top">(unbesetzt)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/03/viewHauptgruppe"><b>03.</a></td><td valign="top">Acidosetherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/04/viewHauptgruppe"><b>04.</a></td><td valign="top">Analeptika/Antihypox&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/05/viewHauptgruppe"><b>05.</a></td><td valign="top">Analgetika/Antirheumatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/06/viewHauptgruppe"><b>06.</a></td><td valign="top">Anthelminthika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/07/viewHauptgruppe"><b>07.</a></td><td valign="top">Antiallergika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/08/viewHauptgruppe"><b>08.</a></td><td valign="top">Antian&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/09/viewHauptgruppe"><b>09.</a></td><td valign="top">Antiarrhythmika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/10/viewHauptgruppe"><b>10.</a></td><td valign="top">Antibiotika/Antiinfektiva</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/11/viewHauptgruppe"><b>11.</a></td><td valign="top">Antidementiva (Nootropika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/12/viewHauptgruppe"><b>12.</a></td><td valign="top">Antidiabetika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/13/viewHauptgruppe"><b>13.</a></td><td valign="top">Antidota</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/14/viewHauptgruppe"><b>14.</a></td><td valign="top">Antiemetika/Antivertiginosa</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/15/viewHauptgruppe"><b>15.</a></td><td valign="top">Antiepileptika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/16/viewHauptgruppe"><b>16.</a></td><td valign="top">Antih&auml;morrhagika (Antifibrinolytika u. andere H&auml;mostatika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/17/viewHauptgruppe"><b>17.</a></td><td valign="top">Antihypertonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/18/viewHauptgruppe"><b>18.</a></td><td valign="top">Antihypoglyk&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/19/viewHauptgruppe"><b>19.</a></td><td valign="top">Antihypotonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/20/viewHauptgruppe"><b>20.</a></td><td valign="top">Antikoagulantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/21/viewHauptgruppe"><b>21.</a></td><td valign="top">Antimykotika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/22/viewHauptgruppe"><b>22.</a></td><td valign="top">Antiparasit&auml;re Mittel (extern)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/23/viewHauptgruppe"><b>23.</a></td><td valign="top">Antiphlogistika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/24/viewHauptgruppe"><b>24.</a></td><td valign="top">Antitussiva/Expektorantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/25/viewHauptgruppe"><b>25.</a></td><td valign="top">Arteriosklerosemittel</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/26/viewHauptgruppe"><b>26.</a></td><td valign="top">Balneotherapeutika u. Mittel zur W&auml;rmetherapie</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/27/viewHauptgruppe"><b>27.</a></td><td valign="top">Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/28/viewHauptgruppe"><b>28.</a></td><td valign="top">Broncholytika/Antiasthmatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/29/viewHauptgruppe"><b>29.</a></td><td valign="top">Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/30/viewHauptgruppe"><b>30.</a></td><td valign="top">Cholinergika</b></td></tr>
</table>
</td>
</tr>
</table>
</body>
</html>

[Mic]

<LINK href="http://www.rote-liste.de/Online/gliederung/praepstyle.css" REL="stylesheet" TYPE="text/css"><table width="100%" border=0 cellpadding=0 cellspacing=0><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td align="right"><a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise</a></td><td>&nbsp;</td></tr></table><table width="100%" border="0"><tr><td valign="top"><table border="0"><tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/01/viewHauptgruppe"><b>01.</a></td><td valign="top">Abmagerungsmittel/Appetitz&uuml;gler</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/02/viewHauptgruppe"><b>02.</a></td><td valign="top">(unbesetzt)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/03/viewHauptgruppe"><b>03.</a></td><td valign="top">Acidosetherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/04/viewHauptgruppe"><b>04.</a></td><td valign="top">Analeptika/Antihypox&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/05/viewHauptgruppe"><b>05.</a></td><td valign="top">Analgetika/Antirheumatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/06/viewHauptgruppe"><b>06.</a></td><td valign="top">Anthelminthika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/07/viewHauptgruppe"><b>07.</a></td><td valign="top">Antiallergika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/08/viewHauptgruppe"><b>08.</a></td><td valign="top">Antian&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/09/viewHauptgruppe"><b>09.</a></td><td valign="top">Antiarrhythmika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/10/viewHauptgruppe"><b>10.</a></td><td valign="top">Antibiotika/Antiinfektiva</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/11/viewHauptgruppe"><b>11.</a></td><td valign="top">Antidementiva (Nootropika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/12/viewHauptgruppe"><b>12.</a></td><td valign="top">Antidiabetika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/13/viewHauptgruppe"><b>13.</a></td><td valign="top">Antidota</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/14/viewHauptgruppe"><b>14.</a></td><td valign="top">Antiemetika/Antivertiginosa</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/15/viewHauptgruppe"><b>15.</a></td><td valign="top">Antiepileptika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/16/viewHauptgruppe"><b>16.</a></td><td valign="top">Antih&auml;morrhagika (Antifibrinolytika u. andere H&auml;mostatika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/17/viewHauptgruppe"><b>17.</a></td><td valign="top">Antihypertonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/18/viewHauptgruppe"><b>18.</a></td><td valign="top">Antihypoglyk&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/19/viewHauptgruppe"><b>19.</a></td><td valign="top">Antihypotonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/20/viewHauptgruppe"><b>20.</a></td><td valign="top">Antikoagulantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/21/viewHauptgruppe"><b>21.</a></td><td valign="top">Antimykotika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/22/viewHauptgruppe"><b>22.</a></td><td valign="top">Antiparasit&auml;re Mittel (extern)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/23/viewHauptgruppe"><b>23.</a></td><td valign="top">Antiphlogistika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/24/viewHauptgruppe"><b>24.</a></td><td valign="top">Antitussiva/Expektorantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/25/viewHauptgruppe"><b>25.</a></td><td valign="top">Arteriosklerosemittel</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/26/viewHauptgruppe"><b>26.</a></td><td valign="top">Balneotherapeutika u. Mittel zur W&auml;rmetherapie</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/27/viewHauptgruppe"><b>27.</a></td><td valign="top">Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/28/viewHauptgruppe"><b>28.</a></td><td valign="top">Broncholytika/Antiasthmatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/29/viewHauptgruppe"><b>29.</a></td><td valign="top">Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/30/viewHauptgruppe"><b>30.</a></td><td valign="top">Cholinergika</b></td></tr>
</table>
</td>
</tr>
</table>
</body>
</html>

[Mic]

<LINK href="http://www.rote-liste.de/Online/gliederung/praepstyle.css" REL="stylesheet" TYPE="text/css"><table width="100%" border=0 cellpadding=0 cellspacing=0><tr><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td align="right"><a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise</a></td><td>&nbsp;</td></tr></table><table width="100%" border="0"><tr><td valign="top"><table border="0"><tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/01/viewHauptgruppe"><b>01.</a></td><td valign="top">Abmagerungsmittel/Appetitz&uuml;gler</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/02/viewHauptgruppe"><b>02.</a></td><td valign="top">(unbesetzt)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/03/viewHauptgruppe"><b>03.</a></td><td valign="top">Acidosetherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/04/viewHauptgruppe"><b>04.</a></td><td valign="top">Analeptika/Antihypox&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/05/viewHauptgruppe"><b>05.</a></td><td valign="top">Analgetika/Antirheumatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/06/viewHauptgruppe"><b>06.</a></td><td valign="top">Anthelminthika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/07/viewHauptgruppe"><b>07.</a></td><td valign="top">Antiallergika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/08/viewHauptgruppe"><b>08.</a></td><td valign="top">Antian&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/09/viewHauptgruppe"><b>09.</a></td><td valign="top">Antiarrhythmika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/10/viewHauptgruppe"><b>10.</a></td><td valign="top">Antibiotika/Antiinfektiva</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/11/viewHauptgruppe"><b>11.</a></td><td valign="top">Antidementiva (Nootropika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/12/viewHauptgruppe"><b>12.</a></td><td valign="top">Antidiabetika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/13/viewHauptgruppe"><b>13.</a></td><td valign="top">Antidota</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/14/viewHauptgruppe"><b>14.</a></td><td valign="top">Antiemetika/Antivertiginosa</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/15/viewHauptgruppe"><b>15.</a></td><td valign="top">Antiepileptika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/16/viewHauptgruppe"><b>16.</a></td><td valign="top">Antih&auml;morrhagika (Antifibrinolytika u. andere H&auml;mostatika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/17/viewHauptgruppe"><b>17.</a></td><td valign="top">Antihypertonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/18/viewHauptgruppe"><b>18.</a></td><td valign="top">Antihypoglyk&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/19/viewHauptgruppe"><b>19.</a></td><td valign="top">Antihypotonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/20/viewHauptgruppe"><b>20.</a></td><td valign="top">Antikoagulantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/21/viewHauptgruppe"><b>21.</a></td><td valign="top">Antimykotika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/22/viewHauptgruppe"><b>22.</a></td><td valign="top">Antiparasit&auml;re Mittel (extern)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/23/viewHauptgruppe"><b>23.</a></td><td valign="top">Antiphlogistika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/24/viewHauptgruppe"><b>24.</a></td><td valign="top">Antitussiva/Expektorantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/25/viewHauptgruppe"><b>25.</a></td><td valign="top">Arteriosklerosemittel</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/26/viewHauptgruppe"><b>26.</a></td><td valign="top">Balneotherapeutika u. Mittel zur W&auml;rmetherapie</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/27/viewHauptgruppe"><b>27.</a></td><td valign="top">Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/28/viewHauptgruppe"><b>28.</a></td><td valign="top">Broncholytika/Antiasthmatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/29/viewHauptgruppe"><b>29.</a></td><td valign="top">Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/30/viewHauptgruppe"><b>30.</a></td><td valign="top">Cholinergika</b></td></tr></table></td></tr></table>

[Mic]

<a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise</a><table width="100%" border="0"><tr><td valign="top"><table border="0"><tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/01/viewHauptgruppe"><b>01.</a></td><td valign="top">Abmagerungsmittel/Appetitz&uuml;gler</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/02/viewHauptgruppe"><b>02.</a></td><td valign="top">(unbesetzt)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/03/viewHauptgruppe"><b>03.</a></td><td valign="top">Acidosetherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/04/viewHauptgruppe"><b>04.</a></td><td valign="top">Analeptika/Antihypox&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/05/viewHauptgruppe"><b>05.</a></td><td valign="top">Analgetika/Antirheumatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/06/viewHauptgruppe"><b>06.</a></td><td valign="top">Anthelminthika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/07/viewHauptgruppe"><b>07.</a></td><td valign="top">Antiallergika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/08/viewHauptgruppe"><b>08.</a></td><td valign="top">Antian&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/09/viewHauptgruppe"><b>09.</a></td><td valign="top">Antiarrhythmika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/10/viewHauptgruppe"><b>10.</a></td><td valign="top">Antibiotika/Antiinfektiva</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/11/viewHauptgruppe"><b>11.</a></td><td valign="top">Antidementiva (Nootropika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/12/viewHauptgruppe"><b>12.</a></td><td valign="top">Antidiabetika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/13/viewHauptgruppe"><b>13.</a></td><td valign="top">Antidota</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/14/viewHauptgruppe"><b>14.</a></td><td valign="top">Antiemetika/Antivertiginosa</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/15/viewHauptgruppe"><b>15.</a></td><td valign="top">Antiepileptika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/16/viewHauptgruppe"><b>16.</a></td><td valign="top">Antih&auml;morrhagika (Antifibrinolytika u. andere H&auml;mostatika)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/17/viewHauptgruppe"><b>17.</a></td><td valign="top">Antihypertonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/18/viewHauptgruppe"><b>18.</a></td><td valign="top">Antihypoglyk&auml;mika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/19/viewHauptgruppe"><b>19.</a></td><td valign="top">Antihypotonika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/20/viewHauptgruppe"><b>20.</a></td><td valign="top">Antikoagulantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/21/viewHauptgruppe"><b>21.</a></td><td valign="top">Antimykotika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/22/viewHauptgruppe"><b>22.</a></td><td valign="top">Antiparasit&auml;re Mittel (extern)</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/23/viewHauptgruppe"><b>23.</a></td><td valign="top">Antiphlogistika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/24/viewHauptgruppe"><b>24.</a></td><td valign="top">Antitussiva/Expektorantia</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/25/viewHauptgruppe"><b>25.</a></td><td valign="top">Arteriosklerosemittel</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/26/viewHauptgruppe"><b>26.</a></td><td valign="top">Balneotherapeutika u. Mittel zur W&auml;rmetherapie</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/27/viewHauptgruppe"><b>27.</a></td><td valign="top">Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/28/viewHauptgruppe"><b>28.</a></td><td valign="top">Broncholytika/Antiasthmatika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/29/viewHauptgruppe"><b>29.</a></td><td valign="top">Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td valign="top"><a href="http://www.rote-liste.de/Online/gliederung/30/viewHauptgruppe"><b>30.</a></td><td valign="top">Cholinergika</b></td></tr></table></td></tr></table>

[Mic]

<html>
<HEAD>
<base href="http://www.rote-liste.de/Online/gliederung/">
<LINK href="praepstyle.css" REL="stylesheet" TYPE="text/css">
<style type="text/css">
<!--
p, b, table, tr, td { white-space:nowrap; }
-->
</style>
</HEAD>
<body>
<b style="color:crimson; font-size=300%;"><img src="http://www.rote-liste.de/Online/jsearch_gliederung/images/RL_online_logo.gif">Inhaltsverzeichnis nach Hauptgruppen</b><p align=center><a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise zur Hauptgruppeneinteilung</a></p>
<table width="100%" border="0">
<tr>

<td valign="top">
<table border="0" style="white-space:nowrap;">
<tr><td><a href="01/viewHauptgruppe"><b>01.</a></td><td>Abmagerungsmittel/Appetitzügler</b></td></tr>
<tr><td><a href="02/viewHauptgruppe"><b>02.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="03/viewHauptgruppe"><b>03.</a></td><td>Acidosetherapeutika</b></td></tr>
<tr><td><a href="04/viewHauptgruppe"><b>04.</a></td><td>Analeptika/Antihypoxämika</b></td></tr>
<tr><td><a href="05/viewHauptgruppe"><b>05.</a></td><td>Analgetika/Antirheumatika</b></td></tr>
<tr><td><a href="06/viewHauptgruppe"><b>06.</a></td><td>Anthelminthika</b></td></tr>
<tr><td><a href="07/viewHauptgruppe"><b>07.</a></td><td>Antiallergika</b></td></tr>
<tr><td><a href="08/viewHauptgruppe"><b>08.</a></td><td>Antianämika</b></td></tr>
<tr><td><a href="09/viewHauptgruppe"><b>09.</a></td><td>Antiarrhythmika</b></td></tr>
<tr><td><a href="10/viewHauptgruppe"><b>10.</a></td><td>Antibiotika/Antiinfektiva</b></td></tr>
<tr><td><a href="11/viewHauptgruppe"><b>11.</a></td><td>Antidementiva (Nootropika)</b></td></tr>
<tr><td><a href="12/viewHauptgruppe"><b>12.</a></td><td>Antidiabetika</b></td></tr>
<tr><td><a href="13/viewHauptgruppe"><b>13.</a></td><td>Antidota</b></td></tr>
<tr><td><a href="14/viewHauptgruppe"><b>14.</a></td><td>Antiemetika/Antivertiginosa</b></td></tr>
<tr><td><a href="15/viewHauptgruppe"><b>15.</a></td><td>Antiepileptika</b></td></tr>
<tr><td><a href="16/viewHauptgruppe"><b>16.</a></td><td>Antihämorrhagika (Antifibrinolytika u. andere Hämostatika)</b></td></tr>
<tr><td><a href="17/viewHauptgruppe"><b>17.</a></td><td>Antihypertonika</b></td></tr>
<tr><td><a href="18/viewHauptgruppe"><b>18.</a></td><td>Antihypoglykämika</b></td></tr>
<tr><td><a href="19/viewHauptgruppe"><b>19.</a></td><td>Antihypotonika</b></td></tr>
<tr><td><a href="20/viewHauptgruppe"><b>20.</a></td><td>Antikoagulantia</b></td></tr>
<tr><td><a href="21/viewHauptgruppe"><b>21.</a></td><td>Antimykotika</b></td></tr>
<tr><td><a href="22/viewHauptgruppe"><b>22.</a></td><td>Antiparasitäre Mittel (extern)</b></td></tr>
<tr><td><a href="23/viewHauptgruppe"><b>23.</a></td><td>Antiphlogistika</b></td></tr>
<tr><td><a href="24/viewHauptgruppe"><b>24.</a></td><td>Antitussiva/Expektorantia</b></td></tr>
<tr><td><a href="25/viewHauptgruppe"><b>25.</a></td><td>Arteriosklerosemittel</b></td></tr>
<tr><td><a href="26/viewHauptgruppe"><b>26.</a></td><td>Balneotherapeutika u. Mittel zur Wärmetherapie</b></td></tr>
<tr><td><a href="27/viewHauptgruppe"><b>27.</a></td><td>Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td><a href="28/viewHauptgruppe"><b>28.</a></td><td>Broncholytika/Antiasthmatika</b></td></tr>
<tr><td><a href="29/viewHauptgruppe"><b>29.</a></td><td>Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td><a href="30/viewHauptgruppe"><b>30.</a></td><td>Cholinergika</b></td></tr>
<tr><td><a href="31/viewHauptgruppe"><b>31.</a></td><td>Corticoide (Interna)</b></td></tr>
<tr><td><a href="32/viewHauptgruppe"><b>32.</a></td><td>Dermatika</b></td></tr>
<tr><td><a href="33/viewHauptgruppe"><b>33.</a></td><td>Desinfizientia/Antiseptika</b></td></tr>
<tr><td><a href="34/viewHauptgruppe"><b>34.</a></td><td>Diätetika/Ernährungstherapeutika</b></td></tr>
<tr><td><a href="35/viewHauptgruppe"><b>35.</a></td><td>Diagnostika u. Mittel zur Diagnosevorbereitung</b></td></tr>
<tr><td><a href="36/viewHauptgruppe"><b>36.</a></td><td>Diuretika</b></td></tr>
<tr><td><a href="37/viewHauptgruppe"><b>37.</a></td><td>Durchblutungsfördernde Mittel</b></td></tr>
<tr><td><a href="38/viewHauptgruppe"><b>38.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="39/viewHauptgruppe"><b>39.</a></td><td>Entwöhnungsmittel/Mittel zur Behandlung von Suchterkrankungen</b></td></tr>
<tr><td><a href="40/viewHauptgruppe"><b>40.</a></td><td>Enzyminhibitoren, Präparate b. Enzymmangel u. Transportproteine</b></td></tr>
<tr><td><a href="41/viewHauptgruppe"><b>41.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="42/viewHauptgruppe"><b>42.</a></td><td>Fibrinolytika</b></td></tr>
<tr><td><a href="43/viewHauptgruppe"><b>43.</a></td><td>Geriatrika</b></td></tr>
<tr><td><a href="44/viewHauptgruppe"><b>44.</a></td><td>Gichtmittel</b></td></tr>
<tr><td><a href="45/viewHauptgruppe"><b>45.</a></td><td>Grippemittel u. Mittel gegen Erkältungskrankheiten</b></td></tr>
</table>
</td>
</table>
</td>
</tr>
</table>
</body>
</html>

[Mic]

<HEAD><base href="http://www.rote-liste.de/Online/gliederung/"><LINK href="praepstyle.css" REL="stylesheet" TYPE="text/css"><style type="text/css"><!-- p, b, table, tr, td { white-space:nowrap; } --> </style></HEAD><body><b style="color:crimson; font-size=300%;"><img src="http://www.rote-liste.de/Online/jsearch_gliederung/images/RL_online_logo.gif">&nbsp;&nbsp;Inhaltsverzeichnis nach Hauptgruppen</b><p align=center><a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise zur Hauptgruppeneinteilung</a></p><table width="100%" border="0"><tr><td valign="top"><table border="0"><tr><td><a href="01/viewHauptgruppe"><b>01.</a></td><td>Abmagerungsmittel/Appetitzügler</b></td></tr>
<tr><td><a href="02/viewHauptgruppe"><b>02.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="03/viewHauptgruppe"><b>03.</a></td><td>Acidosetherapeutika</b></td></tr>
<tr><td><a href="04/viewHauptgruppe"><b>04.</a></td><td>Analeptika/Antihypoxämika</b></td></tr>
<tr><td><a href="05/viewHauptgruppe"><b>05.</a></td><td>Analgetika/Antirheumatika</b></td></tr>
<tr><td><a href="06/viewHauptgruppe"><b>06.</a></td><td>Anthelminthika</b></td></tr>
<tr><td><a href="07/viewHauptgruppe"><b>07.</a></td><td>Antiallergika</b></td></tr>
<tr><td><a href="08/viewHauptgruppe"><b>08.</a></td><td>Antianämika</b></td></tr>
<tr><td><a href="09/viewHauptgruppe"><b>09.</a></td><td>Antiarrhythmika</b></td></tr>
<tr><td><a href="10/viewHauptgruppe"><b>10.</a></td><td>Antibiotika/Antiinfektiva</b></td></tr>
<tr><td><a href="11/viewHauptgruppe"><b>11.</a></td><td>Antidementiva (Nootropika)</b></td></tr>
<tr><td><a href="12/viewHauptgruppe"><b>12.</a></td><td>Antidiabetika</b></td></tr>
<tr><td><a href="13/viewHauptgruppe"><b>13.</a></td><td>Antidota</b></td></tr>
<tr><td><a href="14/viewHauptgruppe"><b>14.</a></td><td>Antiemetika/Antivertiginosa</b></td></tr>
<tr><td><a href="15/viewHauptgruppe"><b>15.</a></td><td>Antiepileptika</b></td></tr>
<tr><td><a href="16/viewHauptgruppe"><b>16.</a></td><td>Antihämorrhagika (Antifibrinolytika u. andere Hämostatika)</b></td></tr>
<tr><td><a href="17/viewHauptgruppe"><b>17.</a></td><td>Antihypertonika</b></td></tr>
<tr><td><a href="18/viewHauptgruppe"><b>18.</a></td><td>Antihypoglykämika</b></td></tr>
<tr><td><a href="19/viewHauptgruppe"><b>19.</a></td><td>Antihypotonika</b></td></tr>
<tr><td><a href="20/viewHauptgruppe"><b>20.</a></td><td>Antikoagulantia</b></td></tr>
<tr><td><a href="21/viewHauptgruppe"><b>21.</a></td><td>Antimykotika</b></td></tr>
<tr><td><a href="22/viewHauptgruppe"><b>22.</a></td><td>Antiparasitäre Mittel (extern)</b></td></tr>
<tr><td><a href="23/viewHauptgruppe"><b>23.</a></td><td>Antiphlogistika</b></td></tr>
<tr><td><a href="24/viewHauptgruppe"><b>24.</a></td><td>Antitussiva/Expektorantia</b></td></tr>
<tr><td><a href="25/viewHauptgruppe"><b>25.</a></td><td>Arteriosklerosemittel</b></td></tr>
<tr><td><a href="26/viewHauptgruppe"><b>26.</a></td><td>Balneotherapeutika u. Mittel zur Wärmetherapie</b></td></tr>
<tr><td><a href="27/viewHauptgruppe"><b>27.</a></td><td>Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td><a href="28/viewHauptgruppe"><b>28.</a></td><td>Broncholytika/Antiasthmatika</b></td></tr>
<tr><td><a href="29/viewHauptgruppe"><b>29.</a></td><td>Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td><a href="30/viewHauptgruppe"><b>30.</a></td><td>Cholinergika</b></td></tr>
<tr><td><a href="31/viewHauptgruppe"><b>31.</a></td><td>Corticoide (Interna)</b></td></tr>
<tr><td><a href="32/viewHauptgruppe"><b>32.</a></td><td>Dermatika</b></td></tr>
<tr><td><a href="33/viewHauptgruppe"><b>33.</a></td><td>Desinfizientia/Antiseptika</b></td></tr>
<tr><td><a href="34/viewHauptgruppe"><b>34.</a></td><td>Diätetika/Ernährungstherapeutika</b></td></tr>
<tr><td><a href="35/viewHauptgruppe"><b>35.</a></td><td>Diagnostika u. Mittel zur Diagnosevorbereitung</b></td></tr>
<tr><td><a href="36/viewHauptgruppe"><b>36.</a></td><td>Diuretika</b></td></tr>
<tr><td><a href="37/viewHauptgruppe"><b>37.</a></td><td>Durchblutungsfördernde Mittel</b></td></tr>
<tr><td><a href="38/viewHauptgruppe"><b>38.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="39/viewHauptgruppe"><b>39.</a></td><td>Entwöhnungsmittel/Mittel zur Behandlung von Suchterkrankungen</b></td></tr>
<tr><td><a href="40/viewHauptgruppe"><b>40.</a></td><td>Enzyminhibitoren, Präparate b. Enzymmangel u. Transportproteine</b></td></tr>
<tr><td><a href="41/viewHauptgruppe"><b>41.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="42/viewHauptgruppe"><b>42.</a></td><td>Fibrinolytika</b></td></tr>
<tr><td><a href="43/viewHauptgruppe"><b>43.</a></td><td>Geriatrika</b></td></tr>
<tr><td><a href="44/viewHauptgruppe"><b>44.</a></td><td>Gichtmittel</b></td></tr>
<tr><td><a href="45/viewHauptgruppe"><b>45.</a></td><td>Grippemittel u. Mittel gegen Erkältungskrankheiten</b></td></tr>
</table>
</td>
</table></td> </tr></table></body>

[Mic]

<HEAD><base href="http://www.rote-liste.de/Online/gliederung/"><LINK href="praepstyle.css" REL="stylesheet" TYPE="text/css"><style type="text/css"><!-- p, b, table, tr, td { white-space:nowrap; } --> </style></HEAD><body><b style="color:crimson; font-size=300%;"><img src="http://www.rote-liste.de/Online/jsearch_gliederung/images/RL_online_logo.gif">&nbsp;&nbsp;Inhaltsverzeichnis nach Hauptgruppen</b><p align=center><a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise zur Hauptgruppeneinteilung</a></p><table border="0"><tr><td><a href="01/viewHauptgruppe"><b>01.</a></td><td>Abmagerungsmittel/Appetitzügler</b></td></tr>
<tr><td><a href="02/viewHauptgruppe"><b>02.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="03/viewHauptgruppe"><b>03.</a></td><td>Acidosetherapeutika</b></td></tr>
<tr><td><a href="04/viewHauptgruppe"><b>04.</a></td><td>Analeptika/Antihypoxämika</b></td></tr>
<tr><td><a href="05/viewHauptgruppe"><b>05.</a></td><td>Analgetika/Antirheumatika</b></td></tr>
<tr><td><a href="06/viewHauptgruppe"><b>06.</a></td><td>Anthelminthika</b></td></tr>
<tr><td><a href="07/viewHauptgruppe"><b>07.</a></td><td>Antiallergika</b></td></tr>
<tr><td><a href="08/viewHauptgruppe"><b>08.</a></td><td>Antianämika</b></td></tr>
<tr><td><a href="09/viewHauptgruppe"><b>09.</a></td><td>Antiarrhythmika</b></td></tr>
<tr><td><a href="10/viewHauptgruppe"><b>10.</a></td><td>Antibiotika/Antiinfektiva</b></td></tr>
<tr><td><a href="11/viewHauptgruppe"><b>11.</a></td><td>Antidementiva (Nootropika)</b></td></tr>
<tr><td><a href="12/viewHauptgruppe"><b>12.</a></td><td>Antidiabetika</b></td></tr>
<tr><td><a href="13/viewHauptgruppe"><b>13.</a></td><td>Antidota</b></td></tr>
<tr><td><a href="14/viewHauptgruppe"><b>14.</a></td><td>Antiemetika/Antivertiginosa</b></td></tr>
<tr><td><a href="15/viewHauptgruppe"><b>15.</a></td><td>Antiepileptika</b></td></tr>
<tr><td><a href="16/viewHauptgruppe"><b>16.</a></td><td>Antihämorrhagika (Antifibrinolytika u. andere Hämostatika)</b></td></tr>
<tr><td><a href="17/viewHauptgruppe"><b>17.</a></td><td>Antihypertonika</b></td></tr>
<tr><td><a href="18/viewHauptgruppe"><b>18.</a></td><td>Antihypoglykämika</b></td></tr>
<tr><td><a href="19/viewHauptgruppe"><b>19.</a></td><td>Antihypotonika</b></td></tr>
<tr><td><a href="20/viewHauptgruppe"><b>20.</a></td><td>Antikoagulantia</b></td></tr>
<tr><td><a href="21/viewHauptgruppe"><b>21.</a></td><td>Antimykotika</b></td></tr>
<tr><td><a href="22/viewHauptgruppe"><b>22.</a></td><td>Antiparasitäre Mittel (extern)</b></td></tr>
<tr><td><a href="23/viewHauptgruppe"><b>23.</a></td><td>Antiphlogistika</b></td></tr>
<tr><td><a href="24/viewHauptgruppe"><b>24.</a></td><td>Antitussiva/Expektorantia</b></td></tr>
<tr><td><a href="25/viewHauptgruppe"><b>25.</a></td><td>Arteriosklerosemittel</b></td></tr>
<tr><td><a href="26/viewHauptgruppe"><b>26.</a></td><td>Balneotherapeutika u. Mittel zur Wärmetherapie</b></td></tr>
<tr><td><a href="27/viewHauptgruppe"><b>27.</a></td><td>Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr>
<tr><td><a href="28/viewHauptgruppe"><b>28.</a></td><td>Broncholytika/Antiasthmatika</b></td></tr>
<tr><td><a href="29/viewHauptgruppe"><b>29.</a></td><td>Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td><a href="30/viewHauptgruppe"><b>30.</a></td><td>Cholinergika</b></td></tr>
<tr><td><a href="31/viewHauptgruppe"><b>31.</a></td><td>Corticoide (Interna)</b></td></tr>
<tr><td><a href="32/viewHauptgruppe"><b>32.</a></td><td>Dermatika</b></td></tr>
<tr><td><a href="33/viewHauptgruppe"><b>33.</a></td><td>Desinfizientia/Antiseptika</b></td></tr>
<tr><td><a href="34/viewHauptgruppe"><b>34.</a></td><td>Diätetika/Ernährungstherapeutika</b></td></tr>
<tr><td><a href="35/viewHauptgruppe"><b>35.</a></td><td>Diagnostika u. Mittel zur Diagnosevorbereitung</b></td></tr>
<tr><td><a href="36/viewHauptgruppe"><b>36.</a></td><td>Diuretika</b></td></tr>
<tr><td><a href="37/viewHauptgruppe"><b>37.</a></td><td>Durchblutungsfördernde Mittel</b></td></tr>
<tr><td><a href="38/viewHauptgruppe"><b>38.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="39/viewHauptgruppe"><b>39.</a></td><td>Entwöhnungsmittel/Mittel zur Behandlung von Suchterkrankungen</b></td></tr>
<tr><td><a href="40/viewHauptgruppe"><b>40.</a></td><td>Enzyminhibitoren, Präparate b. Enzymmangel u. Transportproteine</b></td></tr>
<tr><td><a href="41/viewHauptgruppe"><b>41.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="42/viewHauptgruppe"><b>42.</a></td><td>Fibrinolytika</b></td></tr>
<tr><td><a href="43/viewHauptgruppe"><b>43.</a></td><td>Geriatrika</b></td></tr>
<tr><td><a href="44/viewHauptgruppe"><b>44.</a></td><td>Gichtmittel</b></td></tr>
<tr><td><a href="45/viewHauptgruppe"><b>45.</a></td><td>Grippemittel u. Mittel gegen Erkältungskrankheiten</b></td></tr>
</table>
</body>

[Mic]

<HEAD><base href="http://www.rote-liste.de/Online/gliederung/"><LINK href="praepstyle.css" REL="stylesheet" TYPE="text/css"><style type="text/css"><!-- p, b, table, tr, td { white-space:nowrap; } --> </style></HEAD><body><b style="color:crimson; font-size=300%;"><img src="http://www.rote-liste.de/Online/jsearch_gliederung/images/RL_online_logo.gif">&nbsp;&nbsp;Inhaltsverzeichnis nach Hauptgruppen</b><p align=center><a target="_blank" href="http://www.rote-liste.de/Online/texte/gliedallgemein.html">Hinweise zur Hauptgruppeneinteilung</a></p><table border="0"><tr><td><a href="01/viewHauptgruppe"><b>01.</a></td><td>Abmagerungsmittel/Appetitzügler</b></td></tr><tr><td><a href="02/viewHauptgruppe"><b>02.</a></td><td>(unbesetzt)</b></td></tr><tr><td><a href="03/viewHauptgruppe"><b>03.</a></td><td>Acidosetherapeutika</b></td></tr><tr><td><a href="04/viewHauptgruppe"><b>04.</a></td><td>Analeptika/Antihypoxämika</b></td></tr><tr><td><a href="05/viewHauptgruppe"><b>05.</a></td><td>Analgetika/Antirheumatika</b></td></tr><tr><td><a href="06/viewHauptgruppe"><b>06.</a></td><td>Anthelminthika</b></td></tr><tr><td><a href="07/viewHauptgruppe"><b>07.</a></td><td>Antiallergika</b></td></tr><tr><td><a href="08/viewHauptgruppe"><b>08.</a></td><td>Antianämika</b></td></tr><tr><td><a href="09/viewHauptgruppe"><b>09.</a></td><td>Antiarrhythmika</b></td></tr><tr><td><a href="10/viewHauptgruppe"><b>10.</a></td><td>Antibiotika/Antiinfektiva</b></td></tr><tr><td><a href="11/viewHauptgruppe"><b>11.</a></td><td>Antidementiva (Nootropika)</b></td></tr><tr><td><a href="12/viewHauptgruppe"><b>12.</a></td><td>Antidiabetika</b></td></tr><tr><td><a href="13/viewHauptgruppe"><b>13.</a></td><td>Antidota</b></td></tr><tr><td><a href="14/viewHauptgruppe"><b>14.</a></td><td>Antiemetika/Antivertiginosa</b></td></tr><tr><td><a href="15/viewHauptgruppe"><b>15.</a></td><td>Antiepileptika</b></td></tr><tr><td><a href="16/viewHauptgruppe"><b>16.</a></td><td>Antihämorrhagika (Antifibrinolytika u. andere Hämostatika)</b></td></tr><tr><td><a href="17/viewHauptgruppe"><b>17.</a></td><td>Antihypertonika</b></td></tr><tr><td><a href="18/viewHauptgruppe"><b>18.</a></td><td>Antihypoglykämika</b></td></tr><tr><td><a href="19/viewHauptgruppe"><b>19.</a></td><td>Antihypotonika</b></td></tr> <tr><td><a href="20/viewHauptgruppe"><b>20.</a></td><td>Antikoagulantia</b></td></tr> <tr><td><a href="21/viewHauptgruppe"><b>21.</a></td><td>Antimykotika</b></td></tr> <tr><td><a href="22/viewHauptgruppe"><b>22.</a></td><td>Antiparasitäre Mittel (extern)</b></td></tr> <tr><td><a href="23/viewHauptgruppe"><b>23.</a></td><td>Antiphlogistika</b></td></tr> <tr><td><a href="24/viewHauptgruppe"><b>24.</a></td><td>Antitussiva/Expektorantia</b></td></tr> <tr><td><a href="25/viewHauptgruppe"><b>25.</a></td><td>Arteriosklerosemittel</b></td></tr> <tr><td><a href="26/viewHauptgruppe"><b>26.</a></td><td>Balneotherapeutika u. Mittel zur Wärmetherapie</b></td></tr> <tr><td><a href="27/viewHauptgruppe"><b>27.</a></td><td>Betarezeptoren-, Calciumkanalblocker u. Hemmstoffe d. Renin-Angiotensin-Systems</b></td></tr> <tr><td><a href="28/viewHauptgruppe"><b>28.</a></td><td>Broncholytika/Antiasthmatika</b></td></tr> <tr><td><a href="29/viewHauptgruppe"><b>29.</a></td><td>Cholagoga u. Gallenwegstherapeutika</b></td></tr>
<tr><td><a href="30/viewHauptgruppe"><b>30.</a></td><td>Cholinergika</b></td></tr>
<tr><td><a href="31/viewHauptgruppe"><b>31.</a></td><td>Corticoide (Interna)</b></td></tr>
<tr><td><a href="32/viewHauptgruppe"><b>32.</a></td><td>Dermatika</b></td></tr>
<tr><td><a href="33/viewHauptgruppe"><b>33.</a></td><td>Desinfizientia/Antiseptika</b></td></tr>
<tr><td><a href="34/viewHauptgruppe"><b>34.</a></td><td>Diätetika/Ernährungstherapeutika</b></td></tr>
<tr><td><a href="35/viewHauptgruppe"><b>35.</a></td><td>Diagnostika u. Mittel zur Diagnosevorbereitung</b></td></tr>
<tr><td><a href="36/viewHauptgruppe"><b>36.</a></td><td>Diuretika</b></td></tr>
<tr><td><a href="37/viewHauptgruppe"><b>37.</a></td><td>Durchblutungsfördernde Mittel</b></td></tr>
<tr><td><a href="38/viewHauptgruppe"><b>38.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="39/viewHauptgruppe"><b>39.</a></td><td>Entwöhnungsmittel/Mittel zur Behandlung von Suchterkrankungen</b></td></tr>
<tr><td><a href="40/viewHauptgruppe"><b>40.</a></td><td>Enzyminhibitoren, Präparate b. Enzymmangel u. Transportproteine</b></td></tr>
<tr><td><a href="41/viewHauptgruppe"><b>41.</a></td><td>(unbesetzt)</b></td></tr>
<tr><td><a href="42/viewHauptgruppe"><b>42.</a></td><td>Fibrinolytika</b></td></tr>
<tr><td><a href="43/viewHauptgruppe"><b>43.</a></td><td>Geriatrika</b></td></tr>
<tr><td><a href="44/viewHauptgruppe"><b>44.</a></td><td>Gichtmittel</b></td></tr>
<tr><td><a href="45/viewHauptgruppe"><b>45.</a></td><td>Grippemittel u. Mittel gegen Erkältungskrankheiten</b></td></tr>
</table>
</body>

[Mic]

<html><head><style media=screen type=text/css><!--.body, p { font-weight: lighter; font-size: 9pt; line-height: 12pt; font-family: Arial, Helvetica, Geneva, Swiss, SunSans-Regular; vertical-align: top }td {vertical-align:top; text-align:left}#bg { background-color="#dcdcdc"; }.--></style></head><body><table border=1 cellpadding=2 cellspacing=1 width=400><tr><td colspan=2 bgcolor=silver><p><b>Einfluss von Ovulationshemmern auf laboranalytische Parameter</b></p></td></tr><tr><td><p>Gesamteiwei&szlig;</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Albumin</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Alpha1-Globulin</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Alpha2-Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Beta-Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Gamma-Globulin</p></td><td><p>unver&auml;ndert</p></td></tr><tr><td><p>Immunglobulin A</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Immunglobulin G</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Immunglobulin M</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Rheumafaktor</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>C-reaktives Protein</p></td><td><p>positiv</p></td></tr><tr ID=bg><td><p>Antinukl&auml;rer Antik&ouml;rper</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Gesamteisenbindende Kapazit&auml;t</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Transferrin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Z&auml;ruloplasmin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>H&auml;moglobin</p></td><td><p>unver&auml;ndert</p></td></tr><tr><td><p>Transkortin (CBG)</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Sexualsteroidbindendes Globulin (SHBG)</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Aldosteronbindendes Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Thyroxinbindendes Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Alpha-Antitrypsin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>FIGLU-Ausscheidung (His) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font face=symbol>®</font> Folsäuremangel</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Xanthurens&auml;ureausscheidung (Trp) <font face=symbol>®</font> B6-Mangel</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Laktat</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Pyruvat</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Leucinaminopeptidase</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Gamma-Glutamyltransferase</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Laktatdehydrogenase</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Transaminasen</p></td><td><p>variabel</p></td></tr><tr ID=bg><td><p>Alkalische Phosphatase</p></td><td><p>variabel</p></td></tr><tr><td><p>Alkalische Leukozytenphosphatase</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Cholinesterase</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Lipoproteinlipase</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Gesamtlipide</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Triglyzeride</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>LDL-Cholesterin</p></td><td><p>variabel (erh&ouml;ht)</p></td></tr><tr><td><p>HDL-Cholesterin</p></td><td><p>variabel (erh&ouml;ht)</p></td></tr><tr ID=bg><td><p>Glukose</p></td><td><p>unver&auml;ndert</p></td></tr><tr><td><p>Kalzium</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Phosphat</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Magnesium</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Kupfer</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Eisen</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Zink</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Natrium</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Vitamin A (Retinol)</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Vitamin B1 (Thiamin)</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Vitamin B2 (Riboflavon)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Vitamin B6 (Pyridoxin)</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Vitamin B12 (Cyano-Cobalamin)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Fols&auml;ure</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Vitamin C (Ascorbins&auml;ure)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Vitamin D (Calciferol)</p></td><td><p>unver&auml;ndert</p></td></tr><tr ID=bg><td><p>Vitamin E (Tocopherol)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Pantothens&auml;ure</p></td><td><p>unver&auml;ndert</p></td></tr><tr ID=bg><td><p>Gesamttrijodthyronin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Gesamtthyroxin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Insulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Angiotensin I, II</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>hGH (Wachstumshormon)</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Cortisol</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Aldosteron</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td colspan=2><p style=font-size:7pt>Quelle: Jenaer Symposium zur hormonalen Kontrazeption 1985. Bergmann, M.: Leberver&auml;nderungen unter hormonaler Kontrazeption<br><br>Tab. 1</p></td></tr></table>

[Mic]

<html><head><style media=screen type=text/css><!--.body, p { font-weight: lighter; font-size: 9pt; line-height: 12pt; font-family: Arial, Helvetica, Geneva, Swiss, SunSans-Regular; vertical-align: top }td {vertical-align:top; text-align:left}#bg { background-color="#dcdcdc"; }.--></style></head><body><table border=1 cellpadding=2 cellspacing=1 width=400><tr><td colspan=2 bgcolor=silver><p><b>Einfluss von Ovulationshemmern auf laboranalytische Parameter</b></p></td></tr><tr><td><p>Gesamteiwei&szlig;</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Albumin</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Alpha1-Globulin</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Alpha2-Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Beta-Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Gamma-Globulin</p></td><td><p>unver&auml;ndert</p></td></tr><tr><td><p>Immunglobulin A</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Immunglobulin G</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Immunglobulin M</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Rheumafaktor</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>C-reaktives Protein</p></td><td><p>positiv</p></td></tr><tr ID=bg><td><p>Antinukl&auml;rer Antik&ouml;rper</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Gesamteisenbindende Kapazit&auml;t</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Transferrin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Z&auml;ruloplasmin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>H&auml;moglobin</p></td><td><p>unver&auml;ndert</p></td></tr><tr><td><p>Transkortin (CBG)</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Sexualsteroidbindendes Globulin (SHBG)</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Aldosteronbindendes Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Thyroxinbindendes Globulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Alpha-Antitrypsin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>FIGLU-Ausscheidung (His) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font face=symbol>®</font> Folsäuremangel</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Xanthurens&auml;ureausscheidung (Trp) <font face=symbol>®</font> B6-Mangel</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Laktat</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Pyruvat</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Leucinaminopeptidase</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Gamma-Glutamyltransferase</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Laktatdehydrogenase</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Transaminasen</p></td><td><p>variabel</p></td></tr><tr ID=bg><td><p>Alkalische Phosphatase</p></td><td><p>variabel</p></td></tr><tr><td><p>Alkalische Leukozytenphosphatase</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Cholinesterase</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Lipoproteinlipase</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Gesamtlipide</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Triglyzeride</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>LDL-Cholesterin</p></td><td><p>variabel (erh&ouml;ht)</p></td></tr><tr><td><p>HDL-Cholesterin</p></td><td><p>variabel (erh&ouml;ht)</p></td></tr><tr ID=bg><td><p>Glukose</p></td><td><p>unver&auml;ndert</p></td></tr><tr><td><p>Kalzium</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Phosphat</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Magnesium</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Kupfer</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Eisen</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Zink</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Natrium</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Vitamin A (Retinol)</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Vitamin B1 (Thiamin)</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Vitamin B2 (Riboflavon)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Vitamin B6 (Pyridoxin)</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Vitamin B12 (Cyano-Cobalamin)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Fols&auml;ure</p></td><td><p>erniedrigt</p></td></tr><tr ID=bg><td><p>Vitamin C (Ascorbins&auml;ure)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Vitamin D (Calciferol)</p></td><td><p>unver&auml;ndert</p></td></tr><tr ID=bg><td><p>Vitamin E (Tocopherol)</p></td><td><p>erniedrigt</p></td></tr><tr><td><p>Pantothens&auml;ure</p></td><td><p>unver&auml;ndert</p></td></tr><tr ID=bg><td><p>Gesamttrijodthyronin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Gesamtthyroxin</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Insulin</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Angiotensin I, II</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>hGH (Wachstumshormon)</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td><p>Cortisol</p></td><td><p>erh&ouml;ht</p></td></tr><tr ID=bg><td><p>Aldosteron</p></td><td><p>erh&ouml;ht</p></td></tr><tr><td colspan=2><p style=font-size:7pt>Quelle: Jenaer Symposium zur hormonalen Kontrazeption 1985. Bergmann, M.: Leberver&auml;nderungen unter hormonaler Kontrazeption<br><br>Tab. 1</p></td></tr></table>

[Mic]

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<HTML>
<HEAD>
<SCRIPT LANGUAGE="JavaScript">
<!-- Begin
function showResult(form) {
// Wertübergaben ------------------
wert_1=eval(form.wert_1.value)
wert_2=eval(form.wert_2.value)
wert_3=eval(form.wert_3.value)
botref_1=eval(form.bottom_1.value)
botref_2=eval(form.bottom_2.value)
botref_3=eval(form.bottom_3.value)
topref_1=eval(form.top_1.value)
topref_2=eval(form.top_2.value)
topref_3=eval(form.top_3.value)
// Differenzbildung Gesamtbereich
diff_a_1=topref_1-botref_1
diff_a_2=topref_2-botref_2
diff_a_3=topref_3-botref_3
// Differenzbildung Wertbereich
diff_b_1=wert_1-botref_1
diff_b_2=wert_2-botref_2
diff_b_3=wert_3-botref_3
// Prozentberechnung Ergebnis
prozent_1=100*diff_b_1/diff_a_1
prozent_2=100*diff_b_2/diff_a_2
prozent_3=100*diff_b_3/diff_a_3
// Übergabe Prozent -> Formularausgabe
form.prozent_1.value=prozent_1
form.prozent_2.value=prozent_2
form.prozent_3.value=prozent_3
// Übergabe Prozent -> Balkenbreite
document.balken_1.width=prozent_1
document.balken_2.width=prozent_2
document.balken_3.width=prozent_3
}
// End -->
</SCRIPT>
</HEAD>
<BODY>
<FORM name="formwv">
<table width="700" border="0" cellspacing="0" cellpadding="0">
<colgroup>
<col width="80">
<col width="150">
<col width="50">
<col width="50">
<col width="15">
<col width="50">
<col width="50">
<col width="55">
<col width="200">
</colgroup>

<tr>
<td>Datum/</td>
<td>Name des Laborwertes</td>
<td>Wert</td>
<td align="center" colspan="3">Referenzbereich</td>
<td>Einheit</td>
<td>Ergebnis</td>
<td align="center">Ergebnis grafisch</td>
</tr>
<tr>
<td>Bemerkung</td>
<td></td>
<td></td>
<td align="center">von</td>
<td align="center"></td>
<td align="center">bis</td>
<td></td>
<td>prozentual</td>
<td></td>
</tr>
<tr>
<td><input type=text size=8 value="" name="datum"></td>
<td><input type=text size=20 value="TSH basal" name="name"></td>
<td><input type=text size=5 value="0.7" name="wert_1"></td>
<td><input type=text size=5 value="0.4" name="bottom_1"></td>
<td align="center">-&nbsp;&nbsp;</td>
<td><input type=text size=5 value="4.0" name="top_1"> </td>
<td><input type "text" value="µU/ml" name="einheit" size=5></td>
<td><input type "number" value="" name="prozent_1" size=5 readonly>&nbsp;%</td>
<td>
<div style="position: absolute; top: 60px; left: 565px;">
<img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_1" width="0" height=10>
</div>
<div style="position: absolute; top: 60px; left: 565px;">
<img src="" name="ref" border="1" width="100" height=10>
</div>
</td>
</tr>
<tr>
<td><input type=text size=8 value="" name="datum"></td>
<td><input type=text size=20 value="fT3" name="name"></td>
<td><input type=text size=5 value="2.8" name="wert_2"></td>
<td><input type=text size=5 value="2.3" name="bottom_2"></td>
<td align="center">-&nbsp;&nbsp;</td>
<td><input type=text size=5 value="5.3" name="top_2"></td>
<td><input type "text" value="pg/ml" name="einheit" size=5></td>
<td><input type "number" value="" name="prozent_2" size=5 readonly>&nbsp;%</td>
<td>
<div style="position: absolute; top: 84px; left: 565px;">
<img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_2" width="0" height=10>
</div>
<div style="position: absolute; top: 84px; left: 565px;">
<img src="" name="ref" border="1" width="100" height=10>
</div>
</td>
</tr>
<tr>
<td><input type=text size=8 value="" name="datum"></td>
<td><input type=text size=20 value="fT4" name="name"></td>
<td><input type=text size=5 value="14.5" name="wert_3"></td>
<td><input type=text size=5 value="7.8" name="bottom_3"></td>
<td align="center">-&nbsp;&nbsp;</td>
<td><input type=text size=5 value="17.9" name="top_3"></td>
<td><input type "text" value="pg/ml" name="einheit" size=5></td>
<td><input type "number" value="" name="prozent_3" size=5 readonly>&nbsp;%</td>
<td>
<div style="position: absolute; top: 108px; left: 565px;">
<img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_3" width="0" height=10>
</div>
<div style="position: absolute; top: 108px; left: 565px;">
<img src="" name="ref" border="1" width="100" height=10>
</div>
</td>
</tr>
</table>
</BODY>
</HTML>

[Mic]

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><SCRIPT LANGUAGE="JavaScript">
<!-- Begin
function showResult(form) {
// Wertübergaben ------------------
wert_1=eval(form.wert_1.value)
wert_2=eval(form.wert_2.value)
wert_3=eval(form.wert_3.value)
botref_1=eval(form.bottom_1.value)
botref_2=eval(form.bottom_2.value)
botref_3=eval(form.bottom_3.value)
topref_1=eval(form.top_1.value)
topref_2=eval(form.top_2.value)
topref_3=eval(form.top_3.value)
// Differenzbildung Gesamtbereich
diff_a_1=topref_1-botref_1
diff_a_2=topref_2-botref_2
diff_a_3=topref_3-botref_3
// Differenzbildung Wertbereich
diff_b_1=wert_1-botref_1
diff_b_2=wert_2-botref_2
diff_b_3=wert_3-botref_3
// Prozentberechnung Ergebnis
prozent_1=100*diff_b_1/diff_a_1
prozent_2=100*diff_b_2/diff_a_2
prozent_3=100*diff_b_3/diff_a_3
// Übergabe Prozent -> Formularausgabe
form.prozent_1.value=prozent_1
form.prozent_2.value=prozent_2
form.prozent_3.value=prozent_3
// Übergabe Prozent -> Balkenbreite
document.balken_1.width=prozent_1
document.balken_2.width=prozent_2
document.balken_3.width=prozent_3
}
// End -->
</SCRIPT></HEAD><BODY><FORM name=formwv><table width=700 border=0 cellspacing=0 cellpadding=0><colgroup><col width=80><col width=150><col width=50><col width=50><col width=15><col width=50><col width=50><col width=55><col width=200></colgroup><tr><td>Datum/</td><td>Name des Laborwertes</td><td>Wert</td><td align=center colspan=3>Referenzbereich</td><td>Einheit</td><td>Ergebnis</td><td align=center>Ergebnis grafisch</td></tr><tr><td>Bemerkung</td><td></td><td></td><td align=center>von</td><td align=center></td><td align=center>bis</td><td></td><td>prozentual</td><td></td></tr><tr><td><input type=text size=8 value= name=datum></td><td><input type=text size=20 value="TSH basal" name=name></td><td><input type=text size=5 value=0.7 name=wert_1></td><td><input type=text size=5 value=0.4 name=bottom_1></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value=4.0 name=top_1> </td><td><input type text value=µU/ml name=einheit size=5></td><td><input type number value= name=prozent_1 size=5 readonly>&nbsp;%</td><td><div style=position: absolute; top: 60px; left: 565px;><img src=http://hpu-info.gmxhome.de/images/balken.gif name=balken_1 width=0 height=10></div><div style=position: absolute; top: 60px; left: 565px;><img src= name=ref border=1 width=100 height=10></div></td></tr><tr><td><input type=text size=8 value= name=datum></td><td><input type=text size=20 value=fT3 name=name></td><td><input type=text size=5 value=2.8 name=wert_2></td><td><input type=text size=5 value=2.3 name=bottom_2></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value=5.3 name=top_2></td><td><input type text value=pg/ml name=einheit size=5></td><td><input type number value= name=prozent_2 size=5 readonly>&nbsp;%</td><td><div style=position: absolute; top: 84px; left: 565px;><img src=http://hpu-info.gmxhome.de/images/balken.gif name=balken_2 width=0 height=10></div><div style=position: absolute; top: 84px; left: 565px;><img src= name=ref border=1 width=100 height=10></div></td></tr><tr><td><input type=text size=8 value= name=datum></td><td><input type=text size=20 value=fT4 name=name></td><td><input type=text size=5 value=14.5 name=wert_3></td><td><input type=text size=5 value=7.8 name=bottom_3></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value=17.9 name=top_3></td><td><input type text value=pg/ml name=einheit size=5></td><td><input type number value= name=prozent_3 size=5 readonly>&nbsp;%</td><td><div style=position: absolute; top: 108px; left: 565px;><img src=http://hpu-info.gmxhome.de/images/balken.gif name=balken_3 width=0 height=10></div><div style=position: absolute; top: 108px; left: 565px;><img src= name=ref border=1 width=100 height=10></div></td></tr></table></BODY></HTML>

[Mic]

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><SCRIPT LANGUAGE="JavaScript">
<!-- Begin
function showResult(form) {
// Wertübergaben ------------------
wert_1=eval(form.wert_1.value)
wert_2=eval(form.wert_2.value)
wert_3=eval(form.wert_3.value)
botref_1=eval(form.bottom_1.value)
botref_2=eval(form.bottom_2.value)
botref_3=eval(form.bottom_3.value)
topref_1=eval(form.top_1.value)
topref_2=eval(form.top_2.value)
topref_3=eval(form.top_3.value)
// Differenzbildung Gesamtbereich
diff_a_1=topref_1-botref_1
diff_a_2=topref_2-botref_2
diff_a_3=topref_3-botref_3
// Differenzbildung Wertbereich
diff_b_1=wert_1-botref_1
diff_b_2=wert_2-botref_2
diff_b_3=wert_3-botref_3
// Prozentberechnung Ergebnis
prozent_1=100*diff_b_1/diff_a_1
prozent_2=100*diff_b_2/diff_a_2
prozent_3=100*diff_b_3/diff_a_3
// Übergabe Prozent -> Formularausgabe
form.prozent_1.value=prozent_1
form.prozent_2.value=prozent_2
form.prozent_3.value=prozent_3
// Übergabe Prozent -> Balkenbreite
document.balken_1.width=prozent_1
document.balken_2.width=prozent_2
document.balken_3.width=prozent_3
}
// End -->
</SCRIPT></HEAD><BODY><FORM name="formwv"><table width=700 border=0 cellspacing=0 cellpadding=0><colgroup><col width=80><col width=150><col width=50><col width=50><col width=15><col width=50><col width=50><col width=55><col width=200></colgroup><tr><td>Datum/</td><td>Name des Laborwertes</td><td>Wert</td><td align=center colspan=3>Referenzbereich</td><td>Einheit</td><td>Ergebnis</td><td align=center>Ergebnis grafisch</td></tr><tr><td>Bemerkung</td><td></td><td></td><td align=center>von</td><td align=center></td><td align=center>bis</td><td></td><td>prozentual</td><td></td></tr><tr><td><input type=text size=8 value="" name="datum"></td><td><input type=text size=20 value="TSH basal" name="name"></td><td><input type=text size=5 value="0.7" name="wert_1"></td><td><input type=text size=5 value="0.4" name="bottom_1"></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value="4.0" name="top_1"> </td><td><input type text value="µU/ml" name="einheit" size=5></td><td><input type number value="" name="prozent_1" size=5 readonly>&nbsp;%</td><td><div style=position: absolute; top: 60px; left: 565px;><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_1" width=0 height=10></div><div style=position: absolute; top: 60px; left: 565px;><img src="" name="ref" border=1 width=100 height=10></div></td></tr><tr><td><input type=text size=8 value="" name="datum"></td><td><input type=text size=20 value="fT3" name="name"></td><td><input type=text size=5 value="2.8" name="wert_2"></td><td><input type=text size=5 value="2.3" name="bottom_2"></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value="5.3" name="top_2"></td><td><input type text value="pg/ml" name="einheit" size=5></td><td><input type number value="" name="prozent_2" size=5 readonly>&nbsp;%</td><td><div style=position: absolute; top: 84px; left: 565px;><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_2" width=0 height=10></div><div style=position: absolute; top: 84px; left: 565px;><img src="" name="ref" border=1 width=100 height=10></div></td></tr><tr><td><input type=text size=8 value="" name="datum"></td><td><input type=text size=20 value="fT4" name="name"></td><td><input type=text size=5 value="14.5" name="wert_3"></td><td><input type=text size=5 value="7.8" name="bottom_3"></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value="17.9" name="top_3"></td><td><input type text value="pg/ml" name="einheit" size=5></td><td><input type number value="" name="prozent_3" size=5 readonly>&nbsp;%</td><td><div style=position: absolute; top: 108px; left: 565px;><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_3" width=0 height=10></div><div style=position: absolute; top: 108px; left: 565px;><img src="" name="ref" border=1 width=100 height=10></div></td></tr></table><input type="button" value=" Berechne " onClick="showResult(this.form)"></FORM></BODY></HTML>

[Mic]

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"><HTML><HEAD><SCRIPT LANGUAGE="JavaScript">
<!-- Begin
function showResult(form) {
// Wertübergaben ------------------
wert_1=eval(form.wert_1.value)
wert_2=eval(form.wert_2.value)
wert_3=eval(form.wert_3.value)
botref_1=eval(form.bottom_1.value)
botref_2=eval(form.bottom_2.value)
botref_3=eval(form.bottom_3.value)
topref_1=eval(form.top_1.value)
topref_2=eval(form.top_2.value)
topref_3=eval(form.top_3.value)
// Differenzbildung Gesamtbereich
diff_a_1=topref_1-botref_1
diff_a_2=topref_2-botref_2
diff_a_3=topref_3-botref_3
// Differenzbildung Wertbereich
diff_b_1=wert_1-botref_1
diff_b_2=wert_2-botref_2
diff_b_3=wert_3-botref_3
// Prozentberechnung Ergebnis
prozent_1=100*diff_b_1/diff_a_1
prozent_2=100*diff_b_2/diff_a_2
prozent_3=100*diff_b_3/diff_a_3
// Übergabe Prozent -> Formularausgabe
form.prozent_1.value=prozent_1
form.prozent_2.value=prozent_2
form.prozent_3.value=prozent_3
// Übergabe Prozent -> Balkenbreite
document.balken_1.width=prozent_1
document.balken_2.width=prozent_2
document.balken_3.width=prozent_3
}
// End -->
</SCRIPT></HEAD><BODY><FORM name="formwv"><table width=700 border=0 cellspacing=0 cellpadding=0><colgroup><col width=80><col width=150><col width=50><col width=50><col width=15><col width=50><col width=50><col width=55><col width=200></colgroup><tr><td>Datum/</td><td>Name des Laborwertes</td><td>Wert</td><td align=center colspan=3>Referenzbereich</td><td>Einheit</td><td>Ergebnis</td><td align=center>Ergebnis grafisch</td></tr><tr><td>Bemerkung</td><td></td><td></td><td align=center>von</td><td align=center></td><td align=center>bis</td><td></td><td>prozentual</td><td></td></tr><tr><td><input type=text size=8 value="" name="datum"></td><td><input type=text size=20 value="TSH basal" name="name"></td><td><input type=text size=5 value="0.7" name="wert_1"></td><td><input type=text size=5 value="0.4" name="bottom_1"></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value="4.0" name="top_1"> </td><td><input type text value="µU/ml" name="einheit" size=5></td><td><input type number value="" name="prozent_1" size=5 readonly>&nbsp;%</td><td><div style="position: absolute; top: 60px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_1" width=0 height=10></div><div style="position: absolute; top: 60px; left: 565px;"><img src="" name="ref" border=1 width=100 height=10></div></td></tr><tr><td><input type=text size=8 value="" name="datum"></td><td><input type=text size=20 value="fT3" name="name"></td><td><input type=text size=5 value="2.8" name="wert_2"></td><td><input type=text size=5 value="2.3" name="bottom_2"></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value="5.3" name="top_2"></td><td><input type text value="pg/ml" name="einheit" size=5></td><td><input type number value="" name="prozent_2" size=5 readonly>&nbsp;%</td><td><div style="position: absolute; top: 84px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_2" width=0 height=10></div><div style="position: absolute; top: 84px; left: 565px;"><img src="" name="ref" border=1 width=100 height=10></div></td></tr><tr><td><input type=text size=8 value="" name="datum"></td><td><input type=text size=20 value="fT4" name="name"></td><td><input type=text size=5 value="14.5" name="wert_3"></td><td><input type=text size=5 value="7.8" name="bottom_3"></td><td align=center>-&nbsp;&nbsp;</td><td><input type=text size=5 value="17.9" name="top_3"></td><td><input type text value="pg/ml" name="einheit" size=5></td><td><input type number value="" name="prozent_3" size=5 readonly>&nbsp;%</td><td><div style="position: absolute; top: 108px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken_3" width=0 height=10></div><div style="position: absolute; top: 108px; left: 565px;"><img src="" name="ref" border=1 width=100 height=10></div></td></tr></table><br><input type="button" value=" Berechne " onClick="showResult(this.form)"></FORM></BODY></HTML>

[Mic]

<style type="text/css"> <!-- #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; } --> </style> <div style="position: absolute; top: 0px; left: 0px;"> <table width="700" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td>Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td>prozentual</td> <td></td> </tr> <tr><td id=fr></td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<div style="position: absolute; top: 60px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="8.33" height=10></div><div style="position: absolute; top: 60px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<div style="position: absolute; top: 84px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="16.67" height=10></div><div style="position: absolute; top: 84px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<div style="position: absolute; top: 108px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="66.34" height=10></div><div style="position: absolute; top: 108px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>weitere Laborwerte ...</td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 132px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 132px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 156px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 156px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 180px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 180px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 204px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 204px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 228px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 228px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 252px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 252px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 276px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 276px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

<style type="text/css"> <!-- #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; } --> </style> <div style="position: relative; top: 0px; left: 0px;"> <table width="700" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td>Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td>prozentual</td> <td></td> </tr> <tr><td id=fr></td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<div style="position: absolute; top: 60px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="8.33" height=10></div><div style="position: absolute; top: 60px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<div style="position: absolute; top: 84px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="16.67" height=10></div><div style="position: absolute; top: 84px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<div style="position: absolute; top: 108px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="66.34" height=10></div><div style="position: absolute; top: 108px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>weitere Laborwerte ...</td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 132px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 132px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 156px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 156px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 180px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 180px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 204px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 204px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 228px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 228px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 252px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 252px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 276px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 276px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

Hallo Test,
deine Werte waren:
<style type="text/css"> <!-- #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; } --> </style> <div style="position: relative; top: 0px; left: 0px;"> <table width="700" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td>Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td>prozentual</td> <td></td> </tr> <tr><td id=fr></td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<div style="position: absolute; top: 60px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="8.33" height=10></div><div style="position: absolute; top: 60px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<div style="position: absolute; top: 84px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="16.67" height=10></div><div style="position: absolute; top: 84px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<div style="position: absolute; top: 108px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="66.34" height=10></div><div style="position: absolute; top: 108px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>weitere Laborwerte ...</td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 132px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 132px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 156px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 156px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 180px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 180px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 204px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 204px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 228px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 228px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 252px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 252px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 276px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 276px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

ökjhökjhö
sdklsjdlf
adfadsjäasjdä
<style type="text/css"> <!-- #ts { font:13pt "Trebuchet MS", Arial, Helvetica, sans-serif; } #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; } --> </style> <div style="position: relative; top: 0px; left: 0px;"> <table id="ts" width="700" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td>Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td>prozentual</td> <td></td> </tr> <tr><td id=fr></td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<div style="position: absolute; top: 60px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="8.33" height=10></div><div style="position: absolute; top: 60px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<div style="position: absolute; top: 84px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="16.67" height=10></div><div style="position: absolute; top: 84px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<div style="position: absolute; top: 108px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="66.34" height=10></div><div style="position: absolute; top: 108px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>weitere Laborwerte ...</td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 132px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 132px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 156px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 156px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 180px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 180px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 204px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 204px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 228px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 228px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 252px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 252px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 276px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 276px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

Hallo,
das ist ein Test:
<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; } #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; } --> </style> <div style="position: relative; top: 0px; left: 0px;"> <table id="ts" width="700" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td>Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td>prozentual</td> <td></td> </tr> <tr><td id=fr></td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<div style="position: absolute; top: 60px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="8.33" height=10></div><div style="position: absolute; top: 60px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<div style="position: absolute; top: 84px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="16.67" height=10></div><div style="position: absolute; top: 84px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<div style="position: absolute; top: 108px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="66.34" height=10></div><div style="position: absolute; top: 108px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr>weitere Laborwerte ...</td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 132px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 132px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 156px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 156px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 180px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 180px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 204px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 204px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 228px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 228px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 252px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 252px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr><tr><td id=fr></td><td id=fr></td><td id=frr></td><td id=frc></td><td align="center">- </td><td id=frc></td><td id=frr></td><td id=frr></td><td> %<div style="position: absolute; top: 276px; left: 565px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" name="balken" width="" height=10></div><div style="position: absolute; top: 276px; left: 565px;"><img src="" name="ref" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

Hallo,
das ist noch ein Test:
<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; } #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; padding-right:2px; } --> </style> <div style="position: relative; top: 0px; left: 0px;"> <table id="ts" width="725" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td align="center" colspan="2">Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td align="center" colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>&nbsp;</td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>4</td><td id=fr>&nbsp;</td><td id=frr>&nbsp;</td><td id=frc>&nbsp;</td><td align="center">- </td><td id=frc>&nbsp;</td><td id=frr>&nbsp;</td><td id=frr>&nbsp;</td><td> %<td><div style="position: absolute; top: 124px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="&nbsp;" height=10></div><div style="position: absolute; top: 124px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>5</td><td id=fr>&nbsp;</td><td id=frr>&nbsp;</td><td id=frc>&nbsp;</td><td align="center">- </td><td id=frc>&nbsp;</td><td id=frr>&nbsp;</td><td id=frr>&nbsp;</td><td> %<td><div style="position: absolute; top: 148px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="&nbsp;" height=10></div><div style="position: absolute; top: 148px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>6</td><td id=fr>sadas</td><td id=frr>&nbsp;</td><td id=frc>&nbsp;</td><td align="center">- </td><td id=frc>&nbsp;</td><td id=frr>&nbsp;</td><td id=frr>&nbsp;</td><td> %<td><div style="position: absolute; top: 172px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="&nbsp;" height=10></div><div style="position: absolute; top: 172px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>7</td><td id=fr>&nbsp;</td><td id=frr>&nbsp;</td><td id=frc>&nbsp;</td><td align="center">- </td><td id=frc>&nbsp;</td><td id=frr>&nbsp;</td><td id=frr>&nbsp;</td><td> %<td><div style="position: absolute; top: 196px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="&nbsp;" height=10></div><div style="position: absolute; top: 196px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr> </table></div>

[Mic]

Hallo,
das ist noch ein Test:
<center><style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; } #fr { border:2px inset grey; } #frc { border:2px inset grey; text-align:center; } #frr { border:2px inset grey; text-align:right; padding-right:2px; } --> </style> <div style="position: relative; top: 0px; left: 0px;"> <table id="ts" width="725" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td align="center" colspan="2">Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td>Bemerkung</td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td align="center" colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>*</td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>pg/ml</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>fT4</td><td id=frr>14.5</td><td id=frc>7.8</td><td align="center">- </td><td id=frc>17.9</td><td id=frr>pg/ml</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>4</td><td id=fr>*</td><td id=frr>*</td><td id=frc>*</td><td align="center">- </td><td id=frc>*</td><td id=frr>*</td><td id=frr>*</td><td> %<td><div style="position: absolute; top: 124px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="*" height=10></div><div style="position: absolute; top: 124px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>5</td><td id=fr>*</td><td id=frr>*</td><td id=frc>*</td><td align="center">- </td><td id=frc>*</td><td id=frr>*</td><td id=frr>*</td><td> %<td><div style="position: absolute; top: 148px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="*" height=10></div><div style="position: absolute; top: 148px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>6</td><td id=fr>sadas</td><td id=frr>*</td><td id=frc>*</td><td align="center">- </td><td id=frc>*</td><td id=frr>*</td><td id=frr>*</td><td> %<td><div style="position: absolute; top: 172px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="*" height=10></div><div style="position: absolute; top: 172px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>7</td><td id=fr>*</td><td id=frr>*</td><td id=frc>*</td><td align="center">- </td><td id=frc>*</td><td id=frr>*</td><td id=frr>*</td><td> %<td><div style="position: absolute; top: 196px; left: 600px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="*" height=10></div><div style="position: absolute; top: 196px; left: 600px;"><img src="" border="1" width="100" height=10></div></td></tr> </table></div> </center>

[Mic]

Hallo,
hier mal die Testwerte:
<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #fr { border:2px inset grey; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="875" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="200"> </colgroup> <tr> <td>Datum/</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td align="center">Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>14.05.03</td><td id=fr>Nur ein Beispiel</td><td id=fr>TSH basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 750px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 750px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 750px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 750px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 750px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 750px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>alk. Phosphatase</td><td id=frr>64</td><td id=frc>50</td><td align="center">- </td><td id=frc>160</td><td id=frr>U/l </td><td id=frr>12.73</td><td> %<td><div style="position: absolute; top: 124px; left: 750px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="12.73" height=10></div><div style="position: absolute; top: 124px; left: 750px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #nfr { border:0px inset white; white-space:nowrap; } #fr { border:2px inset white; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="785" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="110"> </colgroup> <tr> <td>Datum</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td>Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>14.05.03</td><td id=fr>Nur&nbsp;ein Beispiel</td><td id=fr>TSH&nbsp;basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>
<pre style="font-family:Fixedsys,Courier; font-size:medium"> <!-- Diese Zeile stehenlassen wenn die Werte in der Antwort als formatierter Text mit Abständen wie eingegeben erscheinen sollen -->
<!-- Wertedarstellung als Hilfe für die Antwort (bleibt normalerweise unsichtbar, diese Zeile zusammen mit dem HTML-Code löschen, wenn man die Werte in dieser Darstellung sichtbar machen und einzeln kommentieren will)
Datum Bezeichnung Wert von bis Einheit Wert/Norm %
14.05.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %
fT3 2.8 2.3 - 5.3 ng/l 16.67 %
fT4 1.45 0.78 - 1.79 ng/dl 66.34 %
------------------------------------------------------------------------------->
</pre> <!-- Diese Zeile stehenlassen, wenn die Werte in der Antwort als formatierter Text mit Abständen wie eingegeben erscheinen sollen -->

[Mic]

><style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #nfr { border:0px inset white; white-space:nowrap; } #fr { border:2px inset white; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="785" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="110"> </colgroup> <tr> <td>Datum</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td>Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>14.05.03</td><td id=fr>Nur*ein Beispiel</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>
<pre style="font-family:Fixedsys,Courier; font-size:medium"> <!-- Diese Zeile stehenlassen wenn die Werte in der Antwort als formatierter Text mit Abständen wie eingegeben erscheinen sollen -->
Datum Bezeichnung Wert von bis Einheit Wert/Norm %
14.05.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %
fT3 2.8 2.3 - 5.3 ng/l 16.67 %
fT4 1.45 0.78 - 1.79 ng/dl 66.34 %
------------------------------------------------------------------------------->
</pre> <!-- Diese Zeile stehenlassen, wenn die Werte in der Antwort als formatierter Text mit Abständen wie eingegeben erscheinen sollen -->

[Mic]

<pre style="font-family:Fixedsys,Courier; font-size:medium"> <!-- Diese Zeile stehenlassen wenn die Werte in der Antwort als formatierter Text mit Abständen wie eingegeben erscheinen sollen -->
Datum Bezeichnung Wert von bis Einheit Wert/Norm %
14.05.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %
fT3 2.8 2.3 - 5.3 ng/l 16.67 %
fT4 1.45 0.78 - 1.79 ng/dl 66.34 %
</pre> <!-- Diese Zeile stehenlassen, wenn die Werte in der Antwort als formatierter Text mit Abständen wie eingegeben erscheinen sollen -->

[Mic]

<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #nfr { border:0px inset white; white-space:nowrap; } #fr { border:2px inset white; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="785" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="110"> </colgroup> <tr> <td>Datum</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td>Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>15.09.03</td><td id=fr>Nur&nbsp;ein Beispiel</td><td id=fr>TSH&nbsp;basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>&nbsp;</td></tr><tr><td id=fr>15.09.03</td><td id=fr>&nbsp;</td><td id=fr>TSH&nbsp;basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>&nbsp;</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 144px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 144px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>&nbsp;</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 168px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 168px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>&nbsp;</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 192px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 192px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>&nbsp;</td></tr><tr><td id=fr>15.09.03</td><td id=fr>&nbsp;</td><td id=fr>TSH&nbsp;basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>&nbsp;</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 236px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 236px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>&nbsp;</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 260px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 260px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>&nbsp;</td><td id=fr>&nbsp;</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>&nbsp;</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 284px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 284px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>

[Mic]

><style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #nfr { border:0px inset white; white-space:nowrap; } #fr { border:2px inset white; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="785" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="110"> </colgroup> <tr> <td>Datum</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td>Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>15.09.03</td><td id=fr>Nur*ein Beispiel</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>*</td></tr><tr><td id=fr>15.09.03</td><td id=fr>*</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>*</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 144px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 144px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>*</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 168px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 168px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>*</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 192px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 192px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>*</td></tr><tr><td id=fr>15.09.03</td><td id=fr>*</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>*</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 236px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 236px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>*</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 260px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 260px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>*</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 284px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 284px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345

[Mic]

<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #nfr { border:0px inset white; white-space:nowrap; } #fr { border:2px inset white; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="785" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="110"> </colgroup> <tr> <td>Datum</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td>Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>15.09.03</td><td id=fr>Nur*ein Beispiel</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>*</td></tr><tr><td id=fr>15.09.03</td><td id=fr>*</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>*</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 144px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 144px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>*</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 168px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 168px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>*</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 192px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 192px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>*</td></tr><tr><td id=fr>15.09.03</td><td id=fr>*</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>*</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 236px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 236px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>*</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 260px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 260px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>*</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 284px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 284px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345

[Mic]

<style type="text/css"> <!-- #ts { font:10pt "Trebuchet MS", Arial, Helvetica, sans-serif; table-layout:fixed; padding-left:2px; white-space:nowrap; } #nfr { border:0px inset white; white-space:nowrap; } #fr { border:2px inset white; white-space:nowrap; } #frc { border:2px inset grey; text-align:center; white-space:nowrap; } #frr { border:2px inset grey; text-align:right; padding-right:2px; white-space:nowrap; } --> </style> <div style="position: relative; top: 10px; left: 10px;"> <table id="ts" width="785" border="0" cellspacing="2" cellpadding="0"> <colgroup> <col width="80"> <col width="150"> <col width="150"> <col width="50"> <col width="50"> <col width="15"> <col width="50"> <col width="50"> <col width="55"> <col width="25"> <col width="110"> </colgroup> <tr> <td>Datum</td> <td>Bemerkung</td> <td>Name des Laborwertes</td> <td>Wert</td> <td align="center" colspan="3">Referenzbereich</td> <td>Einheit</td> <td colspan="2">Ergebnis</td> <td>Ergebnis grafisch</td> </tr> <tr> <td></td> <td></td> <td></td> <td></td> <td align="center">von</td> <td align="center"></td> <td align="center">bis</td> <td></td> <td colspan="2">prozentual</td> <td></td> </tr> <tr><td id=fr>15.09.03</td><td id=fr>Nur*ein Beispiel</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>µU/ml</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 52px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 52px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>ng/l</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 76px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 76px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>ng/dl</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 100px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 100px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>*</td></tr><tr><td id=fr>15.09.03</td><td id=fr>*</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>*</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 144px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 144px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>*</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 168px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 168px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>*</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 192px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 192px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=nfr>*</td></tr><tr><td id=fr>15.09.03</td><td id=fr>*</td><td id=fr>TSH*basal</td><td id=frr>0.7</td><td id=frc>0.4</td><td align="center">- </td><td id=frc>4.0</td><td id=frr>*</td><td id=frr>8.33</td><td> %<td><div style="position: absolute; top: 236px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="8.33" height=10></div><div style="position: absolute; top: 236px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT3</td><td id=frr>2.8</td><td id=frc>2.3</td><td align="center">- </td><td id=frc>5.3</td><td id=frr>*</td><td id=frr>16.67</td><td> %<td><div style="position: absolute; top: 260px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="16.67" height=10></div><div style="position: absolute; top: 260px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr><tr><td id=fr>*</td><td id=fr>*</td><td id=fr>fT4</td><td id=frr>1.45</td><td id=frc>0.78</td><td align="center">- </td><td id=frc>1.79</td><td id=frr>*</td><td id=frr>66.34</td><td> %<td><div style="position: absolute; top: 284px; left: 700px;"><img src="http://hpu-info.gmxhome.de/images/balken.gif" width="66.34" height=10></div><div style="position: absolute; top: 284px; left: 700px;"><img src="" border="1" width="100" height=10></div></td></tr> </table> </div>
12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345 12345

[Mic]

<pre style="font-family:Fixedsys,Courier; font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %
15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %
fT3 2.8 2.3 - 5.3 ng/l 16.67 %
fT4 1.45 0.78 - 1.79 ng/dl 64.34 %
</pre>
<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %
15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %
fT3 2.8 2.3 - 5.3 ng/l 16.67 %
fT4 1.45 0.78 - 1.79 ng/dl 64.34 %
</pre>
<pre style="font-family:Fixedsys,Courier; font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %
15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>

[Mic]

<pre style="font-family:Fixedsys,Courier; font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>

[Mic]

<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>

[Mic]

<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>
Problem bei beiden Varianten ist, dass der Forumseditor hinter jede Zeile einen Zeilenumbruch einfügt wenn man den Beitrag abschickt. Bei normalen HTML-Tabellen hängt er all die Zeilenumbrüche dann an die Tabelle an, was zu unschönen Leerräumen unter einer solchen Tabelle führt - manchmal übersieht man bei großen Tabellen sogar, dass da noch Text folgt. Bei der Variante mit dem "Preformatted"-Format (<pre></pre>) macht er dagegen die Leerzeilen zwischen die einzelnen Textzeilen - auch nicht sehr schön (s. oben). Hier kann man nur durch manuelles Entfernen aller "unsichtbaren" Zeilenumbrüche (Zeilenende) und Ersetzen durch den HTML-Zeilenumbruch <br> kosmetisch eingreifen. Der Preformatted-Text wird ausserdem hier im Forum in etwas zu kleiner Schriftart dargestellt, daher erweitere ich das <pre>-Kommando zu <pre style="font-size:medium"> womit die einfache Tabelle letztlich so aussieht:
<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>-------------------------------------------------------------------------<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>
Wenn du jetzt auf Antworten gehst, siehst du ein brauchbares Beispiel für so einen Tabellencode. Einfach abspeichern und als Grundlage für eigene Tabellen nehmen.

[Mic]

<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>Problem bei beiden Varianten ist, dass der Forumseditor hinter jede Zeile einen Zeilenumbruch einfügt wenn man den Beitrag abschickt. Bei normalen HTML-Tabellen hängt er all die Zeilenumbrüche dann an die Tabelle an, was zu unschönen Leerräumen unter einer solchen Tabelle führt - manchmal übersieht man bei großen Tabellen sogar, dass da noch Text folgt. Bei der Variante mit dem "Preformatted"-Format macht er dagegen die Leerzeilen zwischen die einzelnen Textzeilen - auch nicht sehr schön (s. oben). Hier kann man nur durch manuelles Entfernen aller "unsichtbaren" Zeilenumbrüche (Zeilenende) und Ersetzen durch den HTML-Zeilenumbruch <br> kosmetisch eingreifen. Der Preformatted-Text wird ausserdem hier im Forum in etwas zu kleiner Schriftart dargestellt, daher erweitere ich das <pre>-Kommando womit die einfache Tabelle letztlich so aussieht:
<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>-------------------------------------------------------------------------<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>Wenn du jetzt auf Antworten gehst, siehst du ein brauchbares Beispiel für so einen Tabellencode. Einfach abspeichern und als Grundlage für eigene Tabellen nehmen.

[Mic]

<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>Problem bei beiden Varianten ist, dass der Forumseditor hinter jede Zeile einen Zeilenumbruch einfügt wenn man den Beitrag abschickt. Bei normalen HTML-Tabellen hängt er all die Zeilenumbrüche dann an die Tabelle an, was zu unschönen Leerräumen unter einer solchen Tabelle führt - manchmal übersieht man bei großen Tabellen sogar, dass da noch Text folgt. Bei der Variante mit dem "Preformatted"-Format macht er dagegen die Leerzeilen zwischen die einzelnen Textzeilen - auch nicht sehr schön (s. oben). Hier kann man nur durch manuelles Entfernen aller "unsichtbaren" Zeilenumbrüche (Zeilenende) und Ersetzen durch den HTML-Zeilenumbruch kosmetisch eingreifen. Der Preformatted-Text wird ausserdem hier im Forum in etwas zu kleiner Schriftart dargestellt, daher erweitere ich das pre-Kommando womit die einfache Tabelle letztlich so aussieht:
<pre style="font-size:medium">
Datum Bezeichnung Wert von bis Einheit Wert/Norm %<br>-------------------------------------------------------------------------<br>15.09.03 TSH basal 0.7 0.4 - 4.0 µU/ml 8.33 %<br> fT3 2.8 2.3 - 5.3 ng/l 16.67 %<br> fT4 1.45 0.78 - 1.79 ng/dl 64.34 %</pre>Wenn du jetzt auf Antworten gehst, siehst du ein brauchbares Beispiel für so einen Tabellencode. Einfach abspeichern und als Grundlage für eigene Tabellen nehmen.